BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 011498
(484 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 255 bits (651), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 133/306 (43%), Positives = 196/306 (64%), Gaps = 4/306 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DGT VAVK L R Q
Sbjct: 18 PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ 76
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 77 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR--PQGEVNL 366
+V V GT G++APEY TG +EK+DV+ +G++++E+ITG+ D +R +V L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+DW+K ++ +K E +VD L + +++++ VAL C +RPKM V+ MLE
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316
Query: 427 DDLLFR 432
D L R
Sbjct: 317 DGLAER 322
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 249 bits (637), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 130/303 (42%), Positives = 193/303 (63%), Gaps = 4/303 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DG VAVK L R Q
Sbjct: 10 PEV-HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ 68
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR--PQGEVNL 366
+V V G G++APEY TG +EK+DV+ +G++++E+ITG+ D +R +V L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+DW+K ++ +K E +VD L + +++++ VAL C +RPKM V+ MLE
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
Query: 427 DDL 429
D L
Sbjct: 309 DGL 311
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 194 bits (494), Expect = 8e-50, Method: Compositional matrix adjust.
Identities = 108/284 (38%), Positives = 172/284 (60%), Gaps = 4/284 (1%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG 202
L +LE AT+ + +IG G +G VY+G+L DG KVA+K Q +EF+ E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
RH +LV L+G+C E +L+Y+Y++NGNL + L+G ++W+ R+ I +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGY 321
GL YLH ++HRDVKS NILLD + +++DFG++K +++++ V GT GY
Sbjct: 151 GLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
+ PEY G L EKSDVYSFG+++ E++ R+ + S P+ VNL +W + + E+
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+VDP L ++L++ A++C+ + RP MG V+ LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 193 bits (490), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 108/284 (38%), Positives = 171/284 (60%), Gaps = 4/284 (1%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG 202
L +LE AT+ + +IG G +G VY+G+L DG KVA+K Q +EF+ E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
RH +LV L+G+C E +L+Y+Y++NGNL + L+G ++W+ R+ I +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGY 321
GL YLH ++HRDVKS NILLD + +++DFG++K ++++ V GT GY
Sbjct: 151 GLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
+ PEY G L EKSDVYSFG+++ E++ R+ + S P+ VNL +W + + E+
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+VDP L ++L++ A++C+ + RP MG V+ LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 163 bits (412), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 106/298 (35%), Positives = 172/298 (57%), Gaps = 23/298 (7%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 132
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 309 -SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ + +R++GT Y+APE A G + KSD+YSFG++++EIITG VD R + ++ L
Sbjct: 188 QTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLD 245
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + E+ +D K+ S +++ + VA +C+ KRP + V +L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 162 bits (410), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 106/298 (35%), Positives = 171/298 (57%), Gaps = 23/298 (7%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 132
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 309 -SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ + R++GT Y+APE A G + KSD+YSFG++++EIITG VD R + ++ L
Sbjct: 188 QTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLD 245
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + E+ +D K+ S +++ + VA +C+ KRP + V +L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 161 bits (407), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 106/298 (35%), Positives = 170/298 (57%), Gaps = 23/298 (7%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 126
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 181
Query: 309 -SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ R++GT Y+APE A G + KSD+YSFG++++EIITG VD R + ++ L
Sbjct: 182 QXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLD 239
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + E+ +D K+ S +++ + VA +C+ KRP + V +L+
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 155 bits (392), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 106/298 (35%), Positives = 163/298 (54%), Gaps = 23/298 (7%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N GEGG+G+VY+G +++ T VAVK L +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V + +H+NLV LLG+ +G LVY Y NG+L L G PL+W
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG-TPPLSW 123
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 178
Query: 309 -SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+R++GT Y APE A G + KSD+YSFG++++EIITG VD R + ++ L
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLD 236
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + E+ +D K S +++ VA +C+ KRP + V +L+
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDAD-STSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 121 bits (303), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 77/206 (37%), Positives = 116/206 (56%), Gaps = 9/206 (4%)
Query: 154 CEENV---IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK--EFKVEVEVIGRVRHKN 208
C+ N+ IG G +G V+R G+ VAVK L+ AE+ EF EV ++ R+RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V +G + +V EY+ G+L + LH G L R+++ AKG+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
P +VHRD+KS N+L+D+++ +V DFGL++L S + GT ++APE
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX-FLXSKXAAGTPEWMAPEVLR 212
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
NEKSDVYSFG+++ E+ T + P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/207 (36%), Positives = 121/207 (58%), Gaps = 11/207 (5%)
Query: 154 CEENV---IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK--EFKVEVEVIGRVRHKN 208
C+ N+ IG G +G V+R G+ VAVK L+ AE+ EF EV ++ R+RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V +G + +V EY+ G+L + LH G L R+++ AKG+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR-VMGTFGYVAPEYA 327
P +VHR++KS N+L+D+++ +V DFGL++L S ++++++ GT ++APE
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVL 211
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
NEKSDVYSFG+++ E+ T + P
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP 238
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 85/285 (29%), Positives = 152/285 (53%), Gaps = 40/285 (14%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+ P +VHRD++S NI L + A+V+DFGL++ + + + ++G F ++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193
Query: 323 APEY--ACTGMLNEKSDVYSFGILIMEIITGRNPVD-YSRPQGEVNLVDWLKTMVGSRKS 379
APE A EK+D YSF +++ I+TG P D YS G++ ++ ++
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS--YGKIKFINMIR-------- 243
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
EE + P +P+ R+ V C D KRP +++ L
Sbjct: 244 EEGLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 112 bits (281), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 84/285 (29%), Positives = 151/285 (52%), Gaps = 40/285 (14%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+ P +VHRD++S NI L + A+V+DFG ++ + + + ++G F ++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWM 193
Query: 323 APEY--ACTGMLNEKSDVYSFGILIMEIITGRNPVD-YSRPQGEVNLVDWLKTMVGSRKS 379
APE A EK+D YSF +++ I+TG P D YS G++ ++ ++
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS--YGKIKFINMIR-------- 243
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
EE + P +P+ R+ V C D KRP +++ L
Sbjct: 244 EEGLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 84/285 (29%), Positives = 151/285 (52%), Gaps = 40/285 (14%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+ P +VHRD++S NI L + A+V+DF L++ + + + ++G F ++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWM 193
Query: 323 APEY--ACTGMLNEKSDVYSFGILIMEIITGRNPVD-YSRPQGEVNLVDWLKTMVGSRKS 379
APE A EK+D YSF +++ I+TG P D YS G++ ++ ++
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS--YGKIKFINMIR-------- 243
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
EE + P +P+ R+ V C D KRP +++ L
Sbjct: 244 EEGLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 186 WSFGVLMWEVFSEGKIPYE-NRSNSEV 211
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 188 WSFGVLMWEVFSEGKIPYE-NRSNSEV 213
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 188 WSFGVLMWEVFSEGKIPYE-NRSNSEV 213
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 191 WSFGVLMWEVFSEGKIPYE-NRSNSEV 216
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 84/294 (28%), Positives = 145/294 (49%), Gaps = 42/294 (14%)
Query: 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVI 201
LE + L E +IG GG+G VYR G +VAVK ++ Q + + E ++
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
++H N++ L G C++ LV E+ G L++ L G + P DI +N + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP---DILVNWAVQIA 115
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGLAKLLCSERSYVTT 313
+G+ YLH+ ++HRD+KSSNIL+ ++ +++DFGLA+ + TT
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTT 170
Query: 314 RV--MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371
++ G + ++APE M ++ SDV+S+G+L+ E++TG P +G +D L
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RG----IDGLA 221
Query: 372 TMVGSRKSEEVVD-PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
G ++ + P P +K ++ C +PD RP +++ L
Sbjct: 222 VAYGVAMNKLALPIPSTCPEPFAKLME-------DCWNPDPHSRPSFTNILDQL 268
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 103 bits (258), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 87/290 (30%), Positives = 145/290 (50%), Gaps = 35/290 (12%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGIL--SDGTK---VAVKNLLNNRGQAEKE---FKVEV 198
E S + + VIG G +G VY+G+L S G K VA+K L G EK+ F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M++ EY++NG LD++L G+ S L + ++
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVM 316
G A G+ YL VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 155 GIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE SDV+SFGI++ E++T RP E++ + +K +
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMKAINDG 266
Query: 377 RKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+LP M A+ +++ ++C + +RPK ++ +L+
Sbjct: 267 F--------RLPTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSILD 305
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E +F E EV+ ++ H LV+L G C+E
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 208 WSFGVLMWEVFSEGKIPYE-NRSNSEV 233
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L G
Sbjct: 14 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR---MNIILGTAKGLAYLHEGLE 272
C+ LV EY + G+L LHG PL + M+ L ++G+AYLH ++
Sbjct: 71 CLNPV--CLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 123
Query: 273 PK-VVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
PK ++HRD+K N+LL ++ DFG A C ++++T G+ ++APE
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNN-KGSAAWMAPEVFEGS 179
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+EK DV+S+GI++ E+IT R P D G + W G+R P + +
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMW-AVHNGTRP------PLIKNL 230
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
P K + + RC D ++RP M ++ ++
Sbjct: 231 P-----KPIESLMTRCWSKDPSQRPSMEEIVKIM 259
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR---MNIILGTAKGLAYLHEGLE 272
C+ LV EY + G+L LHG PL + M+ L ++G+AYLH ++
Sbjct: 70 CLNPV--CLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 122
Query: 273 PK-VVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
PK ++HRD+K N+LL ++ DFG A C ++++T G+ ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNN-KGSAAWMAPEVFEGS 178
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+EK DV+S+GI++ E+IT R P D G + W G+R P + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMW-AVHNGTRP------PLIKNL 229
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
P K + + RC D ++RP M ++ ++
Sbjct: 230 P-----KPIESLMTRCWSKDPSQRPSMEEIVKIM 258
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 102 bits (254), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 189 WSFGVLMWEVFSEGKIPYE-NRSNSEV 214
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 219 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 267
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 268 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 324
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 325 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 381
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD++++NIL+ +V+DFGLA+L+ E + T R F + APE A
Sbjct: 382 M---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 436
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
G KSDV+SFGIL+ E+ T GR P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP 464
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 100 bits (248), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 31/265 (11%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEP 273
E + + E V G+L L G PL D I T + GL YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 274 KVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM- 331
++VHRD+K N+L++ ++SDFG +K L T GT Y+APE G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPR 200
Query: 332 -LNEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+ +D++S G I+E+ TG+ P + PQ + V K V P++P+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----------VHPEIPE 249
Query: 390 MPASKALKRVLLVALRCVDPDATKR 414
+++A + L+C +PD KR
Sbjct: 250 SMSAEAKAFI----LKCFEPDPDKR 270
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD++++NIL+ +V+DFGLA+L+ E + T R F + APE A
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 353
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
G KSDV+SFGIL+ E+ T GR P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD++++NIL+ +V+DFGLA+L+ E + T R F + APE A
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 353
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
G KSDV+SFGIL+ E+ T GR P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 31/265 (11%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEP 273
E + + E V G+L L G PL D I T + GL YLH+
Sbjct: 75 SENGFIKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 274 KVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM- 331
++VHRD+K N+L++ ++SDFG +K L T GT Y+APE G
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPR 186
Query: 332 -LNEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+ +D++S G I+E+ TG+ P + PQ + V K V P++P+
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----------VHPEIPE 235
Query: 390 MPASKALKRVLLVALRCVDPDATKR 414
+++A + L+C +PD KR
Sbjct: 236 SMSAEAKAFI----LKCFEPDPDKR 256
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 109/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ G L + M+ + A G+AY+ VHR
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 194 DVWSFGILLTELTTKGRVP 212
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 99.0 bits (245), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 87/297 (29%), Positives = 145/297 (48%), Gaps = 33/297 (11%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK- 192
GR +T RE+EA S + E +IG G G V G L VA+K L + ++
Sbjct: 39 GRSFT-REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252
+F E ++G+ H N++RL G G M+V EY++NG+LD +L G + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-- 153
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSY 310
+ ++ G G+ YL + VHRD+ + N+L+D +VSDFGL+++L + +Y
Sbjct: 154 -VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370
TT + APE + SDV+SFG+++ E++ RP + D +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE-----RPYWNMTNRDVI 264
Query: 371 KTMVGSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
++ EE +LP M AL +++ L C D +RP+ ++ +L+A
Sbjct: 265 SSV------EEGY--RLPAPMGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVLDA 310
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 109/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ G L + M+ + A G+AY+ VHR
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 194 DVWSFGILLTELTTKGRVP 212
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 94 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYL-- 147
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 258
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 291
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 90
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 91 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 146
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 255
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 256 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 288
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD++++NIL+ +V+DFGLA+L+ E + T R F + APE A
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 353
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
G KSDV+SFGIL+ E+ T GR P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 260
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 293
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 56 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 114
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 115 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 170
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 171 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 279
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 280 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 312
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 29 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 87
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 88 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 143
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 144 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 252
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 253 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 285
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 55 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 113
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 114 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 169
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 170 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 278
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 279 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 311
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYL-- 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 260
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 293
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+++ EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 92
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 93 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 149 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 257
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 258 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 290
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 95 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYL-- 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y G ++A E
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 259
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 292
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G+ G L + M + A G+AY+ VHR
Sbjct: 75 EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 187 DVWSFGILLTELTTKGRVP 205
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+++ EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 76 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 188 DVWSFGILLTELTTKGRVP 206
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G GG VY L++ T KVA+K + + + K F+ EV ++ H+N+V
Sbjct: 19 LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ E LV EY++ L +++ HG PL+ D +N G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
++VHRD+K NIL+D ++ DFG+AK L T V+GT Y +PE A
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVD 356
+E +D+YS GI++ E++ G P +
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN 213
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 86/297 (28%), Positives = 143/297 (48%), Gaps = 33/297 (11%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK- 192
GR +T RE+EA S + E +IG G G V G L VA+K L + ++
Sbjct: 39 GRSFT-REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252
+F E ++G+ H N++RL G G M+V EY++NG+LD +L G + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-- 153
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
+ ++ G G+ YL + VHRD+ + N+L+D +VSDFGL+++L +
Sbjct: 154 -VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 313 TRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370
T G + APE + SDV+SFG+++ E++ RP + D +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE-----RPYWNMTNRDVI 264
Query: 371 KTMVGSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
++ EE +LP M AL +++ L C D +RP+ ++ +L+A
Sbjct: 265 SSV------EEGY--RLPAPMGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVLDA 310
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 74 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 186 DVWSFGILLTELTTKGRVP 204
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 36/300 (12%)
Query: 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK 192
WG +E++ + + E VIG G +G V RG L K VA+K L + ++
Sbjct: 2 WGSMEFAKEIDVSYVKI--EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR 59
Query: 193 -EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
EF E ++G+ H N++RL G M++ E+++NG LD +L + G + +
Sbjct: 60 REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ-- 117
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSER 308
+ ++ G A G+ YL E VHRD+ + NIL++ +VSDFGL++ L S+
Sbjct: 118 -LVGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173
Query: 309 SYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365
+Y T+ + G + APE SD +S+GI++ E+++ G P Q +N
Sbjct: 174 TY-TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN 232
Query: 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
++ D +LP P L+ L C D RP+ V+ L+
Sbjct: 233 AIE--------------QDYRLPPPPDCPTSLHQLM--LDCWQKDRNARPRFPQVVSALD 276
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 88 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 141
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 200 DVWSFGILLTEIVTHGRIP 218
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 137 RTQFSSLQQLVAYYSKHADGLCHRLTNVCPTSK-------PQTQGLAKDAWEIPRE---- 185
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 186 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKL 242
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G++G L + M + A G+AY+
Sbjct: 243 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER 299
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD++++NIL+ +V+DFGL +L+ E + T R F + APE A
Sbjct: 300 M---NYVHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAA 354
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
G KSDV+SFGIL+ E+ T GR P
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGRVP 382
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G+ G L + M + A G+AY+ VHR
Sbjct: 78 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 131
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 190 DVWSFGILLTELTTKGRVP 208
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 97.4 bits (241), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 90 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 143
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 202 DVWSFGILLTEIVTHGRIP 220
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 97.4 bits (241), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 89 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 142
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 201 DVWSFGILLTEIVTHGRIP 219
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 82 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 194 DVWSFGILLTEIVTHGRIP 212
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 81 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 193 DVWSFGILLTEIVTHGRIP 211
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 84/308 (27%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 24 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 81
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 82 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 138
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVM 316
G G+ YL + VHRD+ + NIL++ +VSDFG++++L E +Y T
Sbjct: 139 GIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE SDV+S+GI++ E+++ RP +++ D +K +
Sbjct: 196 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVIKAIEEG 250
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
+ P M AL +++ L C + + RPK G +++ML D L R+
Sbjct: 251 YRLP-------PPMDCPIALHQLM---LDCWQKERSDRPKFGQIVNML---DKLIRNPNS 297
Query: 437 IGREPSNS 444
+ R S S
Sbjct: 298 LKRTGSES 305
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 85 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 197 DVWSFGILLTEIVTHGRIP 215
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 26/273 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 20 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 80 PQL-AIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE- 334
HRD+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 335 --KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+SDVY+FGI++ E++TG+ P YS +N D + MVG R S + P L K+
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIEMVG-RGS---LSPDLSKV-R 239
Query: 393 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
S KR+ + C+ +RP ++ +E
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 80/281 (28%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V G L K VA+K L + + ++ +F E ++G+ H N++
Sbjct: 38 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L G + M++ E+++NG+LD +L + G + + + ++ G A G+ YL +
Sbjct: 98 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGMKYLADM 154
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG---TFGYVAPEY 326
VHRD+ + NIL++ +VSDFGL++ L + S T T +G + APE
Sbjct: 155 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
SDV+S+GI++ E+++ G P Q +N ++ D
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--------------QDY 257
Query: 386 KL-PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+L P M AL +++ L C D RPK G +++ L+
Sbjct: 258 RLPPPMDCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLD 295
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D+ ++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 75 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 187 DVWSFGILLTEIVTHGRIP 205
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V RG L K VA+K L + ++ EF E ++G+ H N++
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G M++ E+++NG LD +L + G + + + ++ G A G+ YL E
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM 137
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG---TFGYVAPEY 326
VHRD+ + NIL++ +VSDFGL++ L S T T +G + APE
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
SD +S+GI++ E+++ G P Q +N ++ D
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE--------------QDY 240
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+LP P L+ L C D RP+ V+ L+
Sbjct: 241 RLPPPPDCPTSLHQLM--LDCWQKDRNARPRFPQVVSALD 278
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 96.3 bits (238), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/287 (29%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 217 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 266
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 267 PKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 307
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 96.3 bits (238), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 85/291 (29%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGLA++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 96.3 bits (238), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/287 (29%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 43 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 155
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 216 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 265
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 266 PKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 306
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/277 (29%), Positives = 138/277 (49%), Gaps = 34/277 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 92 PQL-AIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGM 331
HRD+KS+NI L ++ DFGLA +E+ S+ ++ G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 332 LNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
N +SDVY+FGI++ E++TG+ P YS +N D + MVG R S + P L
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIEMVG-RGS---LSPDLS 248
Query: 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K+ S KR+ + C+ +RP ++ +E
Sbjct: 249 KV-RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/308 (27%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 3 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 61 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 117
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVM 316
G G+ YL + VHRD+ + NIL++ +VSDFG++++L E +Y T
Sbjct: 118 GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE SDV+S+GI++ E+++ RP +++ D +K +
Sbjct: 175 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVIKAIEEG 229
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
+ P M AL +++ L C + + RPK G +++ML D L R+
Sbjct: 230 YRLP-------PPMDCPIALHQLM---LDCWQKERSDRPKFGQIVNML---DKLIRNPNS 276
Query: 437 IGREPSNS 444
+ R S S
Sbjct: 277 LKRTGSES 284
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/308 (27%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 9 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 66
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 67 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 123
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVM 316
G G+ YL + VHRD+ + NIL++ +VSDFG++++L E +Y T
Sbjct: 124 GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE SDV+S+GI++ E+++ RP +++ D +K +
Sbjct: 181 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVIKAIEEG 235
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
+ P M AL +++ L C + + RPK G +++ML D L R+
Sbjct: 236 YRLP-------PPMDCPIALHQLM---LDCWQKERSDRPKFGQIVNML---DKLIRNPNS 282
Query: 437 IGREPSNS 444
+ R S S
Sbjct: 283 LKRTGSES 290
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 95 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 259
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 260 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 292
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 72/218 (33%), Positives = 116/218 (53%), Gaps = 14/218 (6%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G G V+ G + TKVAVK+L + F E
Sbjct: 4 WEDAWEVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 60
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 117
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+ E + T R F
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKF 172
Query: 320 --GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ APE G KSDV+SFGIL+ EI+T GR P
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 36/292 (12%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+E+EA S + E VIG G +G V G L K VA+K L G EK+ F
Sbjct: 17 KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLG 72
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++ L G + M+V EY++NG+LD +L + G + + + +
Sbjct: 73 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ---LVGM 129
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G + G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 130 LRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 186
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ APE SDV+S+GI++ E+++ RP E+ D +K +
Sbjct: 187 GKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGE-----RPYWEMTNQDVIKAV- 240
Query: 375 GSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
EE +LP M AL +++ L C + RPK +++ML+
Sbjct: 241 -----EEGY--RLPSPMDCPAALYQLM---LDCWQKERNSRPKFDEIVNMLD 282
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 84/287 (29%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 81 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 194 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 243
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 244 PKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 284
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 34/277 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 91 APQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGM 331
HRD+KS+NI L ++ DFGLA +E+ S+ ++ G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 332 LNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
N +SDVY+FGI++ E++TG+ P YS +N D + MVG R S + P L
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIEMVG-RGS---LSPDLS 248
Query: 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K+ S KR+ + C+ +RP ++ +E
Sbjct: 249 KV-RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 84/287 (29%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 18 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 78 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 130
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 191 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 240
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 241 PKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 281
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 95.1 bits (235), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 85/291 (29%), Positives = 142/291 (48%), Gaps = 37/291 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGMLN 333
D+KS+NI L ++ DFGLA +E+ S+ ++ G+ ++APE N
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 334 E---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKV 262
Query: 391 PAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
++ KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 263 RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 307
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 95.1 bits (235), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 95.1 bits (235), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 95.1 bits (235), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 85/291 (29%), Positives = 142/291 (48%), Gaps = 37/291 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 36 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 96 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 148
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGMLN 333
D+KS+NI L ++ DFGLA +E+ S+ ++ G+ ++APE N
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 334 E---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKV 254
Query: 391 PAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
++ KA+KR++ C+ +RP ++ +E LL R +I R
Sbjct: 255 RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE---LLARSLPKIHR 299
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 94.7 bits (234), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 66/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 76 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
+++++NIL+ + +++DFGLA+L+ E + T R F + APE G KS
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 188 DVWSFGILLTEIVTHGRIP 206
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 94.7 bits (234), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 140/280 (50%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 97 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTTRVMGTF--GYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ +L E V + ++A E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 261
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 294
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 94.7 bits (234), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 94.7 bits (234), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 38 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 93
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 94 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 151 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 261
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 262 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 303
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 11 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 66
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 67 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 123
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 234
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 235 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 276
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 28 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 83
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 84 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 140
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 141 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 251
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 252 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 293
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 81 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 194 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 243
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
KA+KR++ C+ +RP ++ +E
Sbjct: 244 PKAMKRLM---AECLKKKRDERPLFPQILASIE 273
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/291 (28%), Positives = 139/291 (47%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V EY++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL ++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V G L K VA+K L + + ++ +F E ++G+ H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L G + M++ E+++NG+LD +L + G + + + ++ G A G+ YL +
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGMKYLADM 128
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG---TFGYVAPEY 326
VHR + + NIL++ +VSDFGL++ L + S T T +G + APE
Sbjct: 129 ---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
SDV+S+GI++ E+++ G P Q +N ++ D
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--------------QDY 231
Query: 386 KL-PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+L P M AL +++ L C D RPK G +++ L+
Sbjct: 232 RLPPPMDCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLD 269
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 76 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 189 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 238
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
KA+KR++ C+ +RP ++ +E
Sbjct: 239 PKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 70/255 (27%), Positives = 130/255 (50%), Gaps = 21/255 (8%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLVR 211
N++G+G + VYR + G +VA+K +++ + + + + EV++ +++H +++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L Y + Y LV E NG ++++L V P + + + + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACT 329
++HRD+ SN+LL R N +++DFGLA L E+ Y + GT Y++PE A
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEIATR 186
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN---LVDWLKTMVGSRKSEEVVDPK 386
+SDV+S G + ++ GR P D + +N L D+ S ++++++
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 387 LPKMPASK-ALKRVL 400
L + PA + +L VL
Sbjct: 247 LRRNPADRLSLSSVL 261
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNE--- 334
D+KS+NI L ++ DFGLA + S+ ++ G+ ++APE N
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS- 393
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+ ++
Sbjct: 189 QSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKVRSNC 238
Query: 394 -KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
KA+KR++ C+ +RP ++ +E
Sbjct: 239 PKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 34/277 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 76 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLH---AKSIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGMLN 333
D+KS+NI L ++ DFGLA +E+ S+ ++ G+ ++APE N
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 334 E---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+SDVY+FGI++ E++TG+ P YS +N D + MVG + P L K+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP--YS----NINNRDQIIFMVG----RGYLSPDLSKV 234
Query: 391 PAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
++ KA+KR++ C+ +RP ++ +E
Sbjct: 235 RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFG 320
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 169 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 154
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 155 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 210
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 319
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 320 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 352
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFG 320
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 146 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFG 320
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 140 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 97 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 261
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 262 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 294
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 94 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 147
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 258
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 259 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 291
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 260
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 293
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 42 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 100
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 101 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 154
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 265
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 266 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 298
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 85/272 (31%), Positives = 137/272 (50%), Gaps = 37/272 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+GI + +G VA+K L G +A EF E ++ + H +LV
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + LV + + +G L +++H ++G L W +++ AKG+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 156
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
E ++VHRD+ + N+L+ + +++DFGLA+LL E+ Y ++A E
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+SDV+S+G+ I E++T G P D P E+ D L+ K E
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KGE----- 259
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+LP+ P V +V ++C DA RPK
Sbjct: 260 RLPQPPICTI--DVYMVMVKCWMIDADSRPKF 289
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + G ++A E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ R+ ++ P+
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 260
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P + V L+C P A RP ++ + A
Sbjct: 261 YCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 293
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ + TKVAVK + E F E V+ ++H LV+L
Sbjct: 20 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 78
Query: 216 CV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E Y ++ E++ G+L +L D G PL I + + A+G+A++ +
Sbjct: 79 VTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---N 131
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGML 332
+HRD++++NIL+ +++DFGLA+++ E + T R F + APE G
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+MEI+T GR P
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIP 212
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 85/271 (31%), Positives = 136/271 (50%), Gaps = 37/271 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+GI + +G VA+K L G +A EF E ++ + H +LVR
Sbjct: 22 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + LV + + +G L +++H ++G L W +++ AKG+ YL
Sbjct: 82 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 134
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYA 327
E ++VHRD+ + N+L+ + +++DFGLA+LL E+ Y ++A E
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+SDV+S+G+ I E++T G P D P E+ D L+ G R
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLEK--GER--------- 237
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417
LP+ P V +V ++C DA RPK
Sbjct: 238 LPQPPICTI--DVYMVMVKCWMIDADSRPKF 266
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 78/249 (31%), Positives = 121/249 (48%), Gaps = 25/249 (10%)
Query: 112 RGTGSACETASFGSGSVGPEVSHLGWGR--WYTLRELEAATSGLCEENVIGEGGYGIVYR 169
+G C+ S S P+ W + W RE L E +G G +G V+
Sbjct: 156 KGNDGLCQKLSVPCMSSKPQKP---WEKDAWEIPRE------SLKLEKKLGAGQFGEVWM 206
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEY 228
+ TKVAVK + E F E V+ ++H LV+L E Y ++ E+
Sbjct: 207 ATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVTKEPIY--IITEF 263
Query: 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+ G+L +L D G PL I + + A+G+A++ + +HRD++++NIL+
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIM 346
+++DFGLA+++ E + T R F + APE G KSDV+SFGIL+M
Sbjct: 319 ASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 347 EIIT-GRNP 354
EI+T GR P
Sbjct: 377 EIVTYGRIP 385
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 139/287 (48%), Gaps = 28/287 (9%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
E+EA+ L IG G +G VY+G V + +++ + + F+ EV V+ +
Sbjct: 32 EIEASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
RH N++ +GY + +V ++ + +L + LH V + + + ++I TA+G+
Sbjct: 90 RHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLH--VQETKFQMFQL-IDIARQTAQGM 145
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVA 323
YLH ++HRD+KS+NI L ++ DFGLA + S + G+ ++A
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 324 PE---YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380
PE + +SDVYS+GI++ E++TG P + +N D + MVG
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH------INNRDQIIFMVG----R 252
Query: 381 EVVDPKLPKM--PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
P L K+ KA+KR LVA CV +RP ++ +E
Sbjct: 253 GYASPDLSKLYKNCPKAMKR--LVA-DCVKKVKEERPLFPQILSSIE 296
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V E ++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 95
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V E ++NG+LD +L + + + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGM 152
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 263
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 264 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 34/291 (11%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKV 196
+EL+A + + V+G G +G V G L +K VA+K L G EK+ F
Sbjct: 11 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLG 66
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++G+ H N++RL G + M+V E ++NG+LD +L + + + +
Sbjct: 67 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGM 123
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTR 314
+ G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ +PE SDV+S+GI++ E+++ RP E++ D +K +
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKAV- 234
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E P P M AL +++ L C D RPK ++ +L+
Sbjct: 235 ----DEGYRLP--PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 276
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVA+K L E F E +++ +++H LV+L E
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ L +++ A G+AY+ +HR
Sbjct: 76 EPI-YIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++S+NIL+ +++DFGLA+L+ E + T R F + APE A G KS
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E++T GR P
Sbjct: 188 DVWSFGILLTELVTKGRVP 206
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAV-KNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
S L V+G+G +G + + +V V K L+ + ++ F EV+V+ + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-SPLTWDIRMNIILGTAKGLAYLH 268
++ +G + + EY+ G L G + + S W R++ A G+AYLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTL----RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-------------TRV 315
++HRD+ S N L+ N V+DFGLA+L+ E++ V
Sbjct: 126 SM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL-VDWL-KTM 373
+G ++APE +EK DV+SFGI++ EII G VN D+L +TM
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII------------GRVNADPDYLPRTM 230
Query: 374 VGSRKSEEVVDPKL-PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+D P P S + +RC D D KRP + H LE
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLET 279
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F E E++ ++H+++V+
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---------SPLTWDIRMNIILGTAKG 263
G CVEG ++V+EY+ +G+L+++L D + LT ++I A G
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 322
+ YL VHRD+ + N L+ ++ DFG+++ + S Y V M ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
PE +SDV+S G+++ EI T G+ P
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + C S T + GT Y+ PE M
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 244 HNPSQRPMLREVL 256
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 81/289 (28%), Positives = 139/289 (48%), Gaps = 30/289 (10%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A+ + E VIG G +G V G L K VA+K L + + ++F E
Sbjct: 38 KELDASCIKI--ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N+V L G G M+V E+++NG LD +L G + + + ++
Sbjct: 96 SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL---VGMLR 152
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
G A G+ YL + VHRD+ + NIL++ +VSDFGL++++ + V T G
Sbjct: 153 GIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE SDV+S+GI++ E+++ RP +++ D +K +
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVIKAI--- 261
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
EE P M L +++ L C + +RPK ++ +L+
Sbjct: 262 ---EEGYRLPAP-MDCPAGLHQLM---LDCWQKERAERPKFEQIVGILD 303
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 12/217 (5%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G YG VY G+ + VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+ +
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 173
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ APE + KSDV++FG+L+ EI T G +P
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 89.4 bits (220), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + + F E ++ ++H LVRL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ EY+ G+L +L D G + P D I A+G+AY+ +
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERK---NYI 132
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNE 334
HRD++++N+L+ +++DFGLA+++ E + T R F + APE G
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTI 190
Query: 335 KSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI+T G+ P
Sbjct: 191 KSDVWSFGILLYEIVTYGKIP 211
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 89.0 bits (219), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 82 RLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 237
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 238 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 271
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 89.0 bits (219), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 85 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 240
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 241 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 274
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 89.0 bits (219), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 187
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 247
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 248 HNPSQRPMLREVL 260
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G YG VY G+ VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+ +
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP 173
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ APE + KSDV++FG+L+ EI T G +P
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 270
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 27 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 87 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 139
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 242
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 243 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 276
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 82 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 237
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 238 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 271
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 239
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 240 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 273
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 270
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 88.6 bits (218), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 239 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 272
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 88.6 bits (218), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 239
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 240 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 273
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 46 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 106 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 158
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 261
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 262 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 295
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 270
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 77/249 (30%), Positives = 116/249 (46%), Gaps = 35/249 (14%)
Query: 112 RGTGSACETASFGSGSVGPEVSHLGWGR--WYTLRELEAATSGLCEENVIGEGGYGIVYR 169
+G C+ S S P+ W + W RE L E +G G +G V+
Sbjct: 150 KGNDGLCQKLSVPCMSSKPQKP---WEKDAWEIPRE------SLKLEKKLGAGQFGEVWM 200
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEY 228
+ TKVAVK + E F E V+ ++H LV+L E Y ++ E+
Sbjct: 201 ATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVTKEPIY--IITEF 257
Query: 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+ G+L +L D G PL I + + A+G+A++ + +HRD++++NIL+
Sbjct: 258 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVS 312
Query: 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIM 346
+++DFGLA RV F + APE G KSDV+SFGIL+M
Sbjct: 313 ASLVCKIADFGLA------------RVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 360
Query: 347 EIIT-GRNP 354
EI+T GR P
Sbjct: 361 EIVTYGRIP 369
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 243
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 244 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 277
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 42 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 99 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 208
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++S G+L E + G+ P +
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 239 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 272
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 30/279 (10%)
Query: 133 SHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLN 185
SH+ R + L + E +G+G +G VY + IL+ KV K L
Sbjct: 2 SHMSKKRQWALEDFEIGRP-------LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLE 52
Query: 186 NRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV 245
G E + + EVE+ +RH N++RL GY + L+ EY G + + ++ +
Sbjct: 53 KAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKL 107
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
S I A L+Y H +V+HRD+K N+LL +++DFG +
Sbjct: 108 SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD---YSRPQG 362
S R T + GT Y+ PE M +EK D++S G+L E + G+ P + Y
Sbjct: 165 SSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 221
Query: 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
++ V++ + + +++ L P+ + + R +L
Sbjct: 222 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 239
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 240 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 273
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 230
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 231 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 264
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G +G VY G+ VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+ +
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 173
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ APE + KSDV++FG+L+ EI T G +P
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VAVK ++ +E EF E + + ++ H LV+ G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 219 GAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+V EY+ NG L +L HG + S L + + +G+A+L + +
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+DR +VSDFG+ + + ++ + + APE + KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 337 DVYSFGILIMEIIT-GRNPVD 356
DV++FGIL+ E+ + G+ P D
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD 207
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 33 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 89
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 90 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 145 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 199
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++S G+L E + G+ P +
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPPFE 224
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 81 REPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 195 DVWAFGVLLWEIATYGMSP 213
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 187
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 247
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 248 HNPSQRPMLREVL 260
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
+V EY+ GNL +L + ++ ++L A ++ E LE K +
Sbjct: 99 LEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLYMATQISSAMEYLEKKNFI 152
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 213 DVWAFGVLLWEIATYGMSP 231
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 15 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 71
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 72 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 126
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 127 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 181
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 241
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 242 HNPSQRPMLREVL 254
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRM 183
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 244 HNPSQRPMLREVL 256
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 81 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 195 DVWAFGVLLWEIATYGMSP 213
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 31 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 91 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 246
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ +C DA RPK +I
Sbjct: 247 RLPQPPICTI--DVYMIMRKCWMIDADSRPKFRELI 280
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 20 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 76
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 77 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 132 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 186
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 246
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 247 HNPSQRPMLREVL 259
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDYLPPEMIEGRM 187
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 247
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 248 HNPSQRPMLREVL 260
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 239
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ +C DA RPK +I
Sbjct: 240 RLPQPPICTI--DVYMIMRKCWMIDADSRPKFRELI 273
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 13 LGKGKFGNVYLAREKQRKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 69
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 70 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 124
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 125 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 179
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 239
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 240 HNPSQRPMLREVL 252
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLL-----NNRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV + + +A KE E V+ V + ++
Sbjct: 55 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 115 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 167
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 270
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 271 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 304
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 198 DVWAFGVLLWEIATYGMSP 216
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + + F E ++ ++H LVRL +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E++ G+L +L D G + P D I A+G+AY+ +
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERK---NYI 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNE 334
HRD++++N+L+ +++DFGLA+++ E + T R F + APE G
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTI 189
Query: 335 KSDVYSFGILIMEIIT-GRNP 354
KS+V+SFGIL+ EI+T G+ P
Sbjct: 190 KSNVWSFGILLYEIVTYGKIP 210
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ +C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMRKCWMIDADSRPKFRELI 270
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 18 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ A+G+ YL
Sbjct: 78 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNYL 130
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 233
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 234 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 267
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 93 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 207 DVWAFGVLLWEIATYGMSP 225
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 243
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 244 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 277
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 339
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HR++ + N L+ +V+DFGL++L+ + + APE + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV++FG+L+ EI T G +P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 243
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 244 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 277
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 270
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 239 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 272
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 42 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 99 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRM 208
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++S G+L E + G+ P +
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 85 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 240
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 241 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 274
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 243
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 244 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 277
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 18 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 75 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL ++++FG + S R T + GT Y+ PE M
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 184
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 244
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 245 HNPSQRPMLREVL 257
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 27/229 (11%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLNNR 187
LG R +TL + + +G+G +G VY + IL+ KV K L
Sbjct: 3 LGSKRQWTLEDFDIGRP-------LGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKA 53
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
G E + + EVE+ +RH N++RL GY + L+ EY G + + ++ +S
Sbjct: 54 G-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSR 108
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
I A L+Y H +V+HRD+K N+LL +++DFG + S
Sbjct: 109 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS 165
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
R T + GT Y+ PE M +EK D++S G+L E + G P +
Sbjct: 166 RR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 236
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ ++C DA RPK +I
Sbjct: 237 RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 270
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 18 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 75 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRM 184
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 244
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 245 HNPSQRPMLREVL 257
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKNSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
KV+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 128 --KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++S G+L E + G+ P +
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 379
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HR++ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 440 DVWAFGVLLWEIATYGMSP 458
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL ++++FG + S R T + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRM 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 243 HNPSQRPMLREVL 255
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 76/202 (37%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 18 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 75 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 127
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
VHRD+ + N+L+ A+VSDFGL K S + V T APE +
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFS 183
Query: 334 EKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI + GR P
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVP 205
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DTLCGTLDYLPPEMIEGRM 183
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 244 HNPSQRPMLREVL 256
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 284 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 337
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HR++ + N L+ +V+DFGL++L+ + + APE + KS
Sbjct: 338 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 397
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV++FG+L+ EI T G +P
Sbjct: 398 DVWAFGVLLWEIATYGMSP 416
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R T + GT Y+ PE
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEXIEGRX 187
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++S G+L E + G+ P +
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R + GT Y+ PE M
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRM 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD---YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+EK D++S G+L E + G+ P + Y ++ V++ + + +++ L
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 389 KMPASKALKRVLL 401
P+ + + R +L
Sbjct: 246 HNPSQRPMLREVL 258
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 114/235 (48%), Gaps = 27/235 (11%)
Query: 124 GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183
GS + E GW ++EL+ + IG+G +G V G G KVAVK +
Sbjct: 3 GSVAAQDEFYRSGWA--LNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCI 52
Query: 184 LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---GAYRMLVYEYVDNGNLDQWLHG 240
N+ + F E V+ ++RH NLV+LLG VE G Y +V EY+ G+L +L
Sbjct: 53 KND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRS 108
Query: 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300
V L D + L + + YL EG VHRD+ + N+L+ A+VSDFGL
Sbjct: 109 RGRSV--LGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
K S + V T APE + KSDV+SFGIL+ EI + GR P
Sbjct: 164 TKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ +C DA RPK +I
Sbjct: 239 RLPQPPICTI--DVYMIMRKCWMIDADSRPKFRELI 272
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 37/276 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFG AKLL E+ Y ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+G+ + E++T G P D P E++ + K E
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+LP+ P V ++ +C DA RPK +I
Sbjct: 239 RLPQPPICTI--DVYMIMRKCWMIDADSRPKFRELI 272
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/202 (37%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 256 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 308
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
VHRD+ + N+L+ A+VSDFGL K S + V T APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 334 EKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 73/258 (28%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S +T V GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S GI+ +E+I G P P + L + + + E+ +P+ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE-----KLSAI 245
Query: 397 KRVLLVALRCVDPDATKR 414
R L RC+D D KR
Sbjct: 246 FRDFLN--RCLDMDVEKR 261
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 159 IGEGGYGIVYRG------ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGD----VGDVSP------LTWDIRMNIILGT 260
G C +G ++V+EY+ +G+L+++L HG + D P L ++I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTF 319
A G+ YL VHRD+ + N L+ ++ DFG+++ + S Y V M
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/202 (37%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 121
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
VHRD+ + N+L+ A+VSDFGL K S + V T APE +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177
Query: 334 EKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLNNR 187
LG R +TL + + +G+G +G VY + IL+ KV K L
Sbjct: 3 LGSKRQWTLEDFDIGRP-------LGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKA 53
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
G E + + EVE+ +RH N++RL GY + L+ EY G ++ ++ +S
Sbjct: 54 G-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSR 108
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
I A L+Y H +V+HRD+K N+LL +++DFG + S
Sbjct: 109 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS 165
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
R + GT Y+ PE M +EK D++S G+L E + G P +
Sbjct: 166 RR---DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD 207
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 73/249 (29%), Positives = 115/249 (46%), Gaps = 50/249 (20%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E K+VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYS 358
+ + E SYV R G ++A E + +SDV+SFG+L+ EI+T G NP
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 359 RPQGEVNLV 367
P+ NL+
Sbjct: 257 PPERLFNLL 265
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 20/232 (8%)
Query: 129 GPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG 188
P + LG+G W E++ +E +G G +G+V G VA+K ++
Sbjct: 8 APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ +L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 356
T+ V F + PE + KSD+++FG+L+ EI + G+ P +
Sbjct: 174 EE--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
EG + L EY G L + D+G P ++ G+ YLH G+ +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--GIT 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN-E 334
HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 335 KSDVYSFGILIMEIITGRNPVD 356
DV+S GI++ ++ G P D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
EG + L EY G L + D+G P ++ G+ YLH G+ +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--GIT 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN-E 334
HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 335 KSDVYSFGILIMEIITGRNPVD 356
DV+S GI++ ++ G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S + ++GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S GI+ +E+I G P P + L + + + E+ +P+ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE-----KLSAI 245
Query: 397 KRVLLVALRCVDPDATKR 414
R L RC+D D KR
Sbjct: 246 FRDFLN--RCLDMDVEKR 261
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 20/232 (8%)
Query: 129 GPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG 188
P + LG+G W E++ +E +G G +G+V G VA+K ++
Sbjct: 8 APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ +L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 356
T+ V F + PE + KSD+++FG+L+ EI + G+ P +
Sbjct: 174 E--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLHG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L D D PL ++ A+G+A+L +HRDV + N+LL
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 289 RQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 347
A++ DFGLA+ + ++ +Y+ ++APE + +SDV+S+GIL+ E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 348 IIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRC 406
I + G NP + +V S+ + V D PA A K + + C
Sbjct: 255 IFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQAC 299
Query: 407 VDPDATKRPKMGHVIHMLEADDLLFRDER 435
+ T RP + L+ R ER
Sbjct: 300 WALEPTHRPTFQQICSFLQEQAQEDRRER 328
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 28/259 (10%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 70 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 235 DQWLHG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L D D PL ++ A+G+A+L +HRDV + N+LL
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 186
Query: 289 RQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 347
A++ DFGLA+ + ++ +Y+ ++APE + +SDV+S+GIL+ E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 348 IIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRC 406
I + G NP + +V S+ + V D PA A K + + C
Sbjct: 247 IFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQAC 291
Query: 407 VDPDATKRPKMGHVIHMLE 425
+ T RP + L+
Sbjct: 292 WALEPTHRPTFQQICSFLQ 310
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
E IG G + VYR L DG VA+K +L++ + +A+ E++++ ++ H N+
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNHPNV 94
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ +E +V E D G+L + + + + L ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+V+HRD+K +N+ + ++ D GL + S ++ ++GT Y++PE
Sbjct: 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHE 210
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
N KSD++S G L+ E+ ++P Y ++NL K K E+ P LP
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCK------KIEQCDYPPLPS 260
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHV 420
S+ L++++ + C++PD KRP + +V
Sbjct: 261 DHYSEELRQLVNM---CINPDPEKRPDVTYV 288
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVAPEYA 327
++HRDVK +NIL+ +V DFG+A+ + + V T V+GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
++ +SDVYS G ++ E++TG P P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNN-RGQAEKEFK 195
L+E+ + EE +GE +G VY+G L VA+K L + G +EF+
Sbjct: 20 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV----- 245
E + R++H N+V LLG + +++ Y +G+L ++L H DVG
Sbjct: 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 246 --SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
S L ++++ A G+ YL VVH+D+ + N+L+ + N ++SD GL +
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 304 LCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ + Y + + ++APE G + SD++S+G+++ E+ +
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 26/266 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 88 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S + V GT ++APE K
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S GI+ +E+I G P P + L + + + E+ +P+ A+
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE-----KLSAI 246
Query: 397 KRVLLVALRCVDPDATKRPKMGHVIH 422
R L RC++ D KR +I
Sbjct: 247 FRDFLN--RCLEMDVEKRGSAKELIQ 270
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYA 327
++HRDVK +NI++ +V DFG+A+ + + VT V+GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
++ +SDVYS G ++ E++TG P P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYA 327
++HRDVK +NI++ +V DFG+A+ + + VT V+GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
++ +SDVYS G ++ E++TG P P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 88 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HR++KS NILL + +++DFG + E+S +T V GT ++APE K
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S GI+ +E+I G P P + L + + + E+ +P+ A+
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE-----KLSAI 246
Query: 397 KRVLLVALRCVDPDATKRPKMGHVIH 422
R L RC++ D KR +I
Sbjct: 247 FRDFLN--RCLEMDVEKRGSAKELIQ 270
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 32/286 (11%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++GEG YG+V + D G VA+K L ++ +K E++++ ++RH+NLV LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLAYLHEGLE 272
C + LV+E+VD+ LD ++ P L + + + G+ + H
Sbjct: 92 VCKKKKRWYLVFEFVDHTILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCHSH-- 143
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
++HRD+K NIL+ + ++ DFG A+ L + V T Y APE +
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVK 201
Query: 333 NEKS-DVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP---- 385
K+ DV++ G L+ E+ G P D Q +++ L ++ + +P
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 386 -KLPKMPASKALKR--------VLLVALRCVDPDATKRPKMGHVIH 422
+LP++ + L+R V+ +A +C+ D KRP ++H
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 158 VIGEGGYGIVYRGILS--DGT--KVAVKNL-LNNRGQAE-KEFKVEVEVIGRVRHKNLVR 211
++GEG +G V G L DGT KVAVK + L+N Q E +EF E + H N++R
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 212 LLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGL 264
LLG C+E + + M++ ++ G+L +L + P + + ++ A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYVA 323
YL +HRD+ + N +L V+DFGL+K + S Y R+ ++A
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
E + KSDV++FG+ + EI T G P
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNN-RGQAEKEFK 195
L+E+ + EE +GE +G VY+G L VA+K L + G +EF+
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV----- 245
E + R++H N+V LLG + +++ Y +G+L ++L H DVG
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 246 --SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
S L ++++ A G+ YL VVH+D+ + N+L+ + N ++SD GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 304 LCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ + Y + + ++APE G + SD++S+G+++ E+ +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S + V GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
D++S GI+ +E+I G P P + L+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 26/216 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L +A+ +E E +++ ++ + +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C A MLV E G L ++L G V +V+ L + M G+ YL E
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM--------GMKYLEE 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD+ + N+LL + A++SDFGL+K L ++ SY T R G + + APE
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362
+ +SDV+S+G+ + E ++ G+ P Y + +G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKG 219
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT 190
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 485
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 486 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L +A+ +E E +++ ++ + +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C A MLV E G L ++L G V +V+ L + M G+ YL E
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM--------GMKYLEE 454
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHR++ + N+LL + A++SDFGL+K L ++ SY T R G + + APE
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ +SDV+S+G+ + E ++ G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 72/249 (28%), Positives = 114/249 (45%), Gaps = 50/249 (20%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E K+VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYS 358
+ + E S V R G ++A E + +SDV+SFG+L+ EI+T G NP
Sbjct: 198 RDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 359 RPQGEVNLV 367
P+ NL+
Sbjct: 257 PPERLFNLL 265
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 17/250 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + +V A+K + L ++ + E+ V+ + + + G
Sbjct: 31 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 217 VEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G+ ++ EY+ G+ LD G + T ++ KGL YLH K
Sbjct: 91 LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS---EKK 141
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+K++N+LL Q + +++DFG+A L + T V GT ++APE + K
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 200
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMP 391
+D++S GI +E+ G P P + L+ + T+VG ++ +E +D L K P
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 392 ASKALKRVLL 401
+ + + LL
Sbjct: 261 SFRPTAKELL 270
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 486
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 487 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 193
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ R++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG G V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 334 -EKSDVYSFGILIMEIITGRNPVD 356
E DV+S GI++ ++ G P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HR++ + NIL++ + ++ DFGL K+L ++ Y + G F Y APE
Sbjct: 135 --RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT 191
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 85/307 (27%), Positives = 140/307 (45%), Gaps = 47/307 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+GI + DG VA+K L N +A KE E V+ V +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + LV + + G L + G +G L W +++ AKG++YL
Sbjct: 83 RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
+ ++VHRD+ + N+L+ + +++DFGLA+LL E Y ++A E
Sbjct: 136 EDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+SDV+S+G+ + E++T G P D P E+ D L+ K E
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIP--DLLE------KGE----- 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSY 445
+LP+ P V ++ ++C D+ RP+ ++ R+ R+P
Sbjct: 239 RLPQPPICTI--DVYMIMVKCWMIDSECRPRFRELVSEFS----------RMARDPQRFV 286
Query: 446 GEENRDF 452
+N D
Sbjct: 287 VIQNEDL 293
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 79.0 bits (193), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 20/226 (8%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF 194
LG+G W E++ +E +G G +G+V G VA+K ++ +E EF
Sbjct: 5 LGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEF 57
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
E +V+ + H+ LV+L G C + ++ EY+ NG L +L + +
Sbjct: 58 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EMRHRFQT 110
Query: 255 NIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + + T+
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTS 168
Query: 314 RVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 356
V F + PE + KSD+++FG+L+ EI + G+ P +
Sbjct: 169 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 29 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 89 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 141
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 142 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 194 FKVEVEVIGRVRHKNLVRLLGY----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
F+ E + + H +V + G +V EYVD L +H + P+T
Sbjct: 59 FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMT 114
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+ +I + L + H+ ++HRDVK +NI++ +V DFG+A+ + +
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 YVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
VT V+GT Y++PE A ++ +SDVYS G ++ E++TG P P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 137
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 194
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 91 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 144 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 91 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 144 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 157 NVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G V++G+ S V +K + + G Q+ + + IG + H ++V
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYL 267
RLLG C G+ LV +Y+ G+L + G + P L W +++ AKG+ YL
Sbjct: 97 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
E +VHR++ + N+LL +V+DFG+A LL ++ + + ++A E
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT 350
G +SDV+S+G+ + E++T
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 194 FKVEVEVIGRVRHKNLVRLL----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
F+ E + + H +V + G +V EYVD L +H + P+T
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMT 114
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+ +I + L + H+ ++HRDVK +NI++ +V DFG+A+ + +
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 YVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
VT V+GT Y++PE A ++ +SDVYS G ++ E++TG P P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 2 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 239 H------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ ++P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++ DFG+ + + E Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 177 VKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 138
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 139 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 195
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRH-KNLVRLLGY 215
IG G YG V + + G +AVK + + + E K+ ++++V+ R +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 216 CVEGAYRMLVYEYVDNG--NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ E + ++++ + DV P +I I L T K L +L E L
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP--EEILGKITLATVKALNHLKENL-- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE----YACT 329
K++HRD+K SNILLDR N ++ DFG++ L S TR G Y+APE A
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSASR 203
Query: 330 GMLNEKSDVYSFGILIMEIITGRNP 354
+ +SDV+S GI + E+ TGR P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFP 228
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 189
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 221
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 193
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 141 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 197
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 139
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 140 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 196
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 190
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 190
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 134 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 132 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 188
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ E++ G+L ++L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 193
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 2 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 239 HG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ ++P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 120 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++ DFG+ + + E Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 177 VKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + + TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 208
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 157 NVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G V++G+ S V +K + + G Q+ + + IG + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYL 267
RLLG C G+ LV +Y+ G+L + G + P L W +++ AKG+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEY 326
E +VHR++ + N+LL +V+DFG+A LL ++ + + ++A E
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT 350
G +SDV+S+G+ + E++T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/249 (28%), Positives = 113/249 (45%), Gaps = 50/249 (20%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E +VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYS 358
+ + E S V R G ++A E + +SDV+SFG+L+ EI+T G NP
Sbjct: 198 RDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 359 RPQGEVNLV 367
P+ NL+
Sbjct: 257 PPERLFNLL 265
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 202
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + SDV+S+G+L+ EI++
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 75 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 128 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLG--- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYAC 328
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F Y APE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 208
Query: 329 TGMLNEKSDVYSFGILIMEIIT 350
+ SDV+SFG+++ E+ T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + + TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL---- 212
+G GG+G V R I D G +VA+K +E + +E++++ ++ H N+V
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 213 --LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L EY + G+L ++L+ IR ++ + L YLHE
Sbjct: 83 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 141
Query: 271 LEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
+++HRD+K NI+L ++ ++ D G AK L ++ + T +GT Y+APE
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELL 196
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
D +SFG L E ITG P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 140 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 192
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + SDV+S+G+L+ EI++
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 9 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 69 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 121
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 122 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLHGD-----------VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
+L + + + T D+ ++ A+G+A+L +HRDV +
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDL-LHFSSQVAQGMAFL---ASKNCIHRDVAAR 193
Query: 284 NILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFG 342
N+LL A++ DFGLA+ + ++ +Y+ ++APE + +SDV+S+G
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 343 ILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
IL+ EI + G NP + +V S+ + V D PA A K +
Sbjct: 254 ILLWEIFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF-APKNIYS 298
Query: 402 VALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
+ C + T RP + L+ R ER
Sbjct: 299 IMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL---- 212
+G GG+G V R I D G +VA+K +E + +E++++ ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 213 --LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L EY + G+L ++L+ IR ++ + L YLHE
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 271 LEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
+++HRD+K NI+L ++ ++ D G AK L ++ + T +GT Y+APE
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELL 195
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
D +SFG L E ITG P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 123
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 124 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 9/144 (6%)
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
G +V EYVD L +H + P+T + +I + L + H+ ++HR
Sbjct: 105 GPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHR 157
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYACTGMLNEKS 336
DVK +NI++ +V DFG+A+ + + VT V+GT Y++PE A ++ +S
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 217
Query: 337 DVYSFGILIMEIITGRNPVDYSRP 360
DVYS G ++ E++TG P P
Sbjct: 218 DVYSLGCVLYEVLTGEPPFTGDSP 241
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
KV+HRD+K N+L+ + +++DFG + S R + GT Y+ PE
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RXMCGTLDYLPPEMIEGKT 188
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++ G+L E + G P D
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 159 IGEGGYGIVYR----GILS--DGTKVAVKNLLNNRGQA--EKEFKVEVEVIGRVRHKNLV 210
IGEG +G V++ G+L T VAVK +L A + +F+ E ++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVS--------PLTW 250
+LLG C G L++EY+ G+L+++L H D+ + PL+
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
++ I A G+AYL E K VHRD+ + N L+ +++DFGL++ + S Y
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 311 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++ PE +SDV+++G+++ EI +
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 32/226 (14%)
Query: 158 VIGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
V+G G +G V GI G +VAVK L +E+E E++++ ++ H+N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-------------------DVGDVSPLTW 250
V LLG C L++EY G+L +L + D++ LT+
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+ +Y
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 311 VTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
V ++APE G+ KSDV+S+GIL+ EI + G NP
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 82 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
KV+HRD+K N+L+ + +++DFG + S R + GT Y+ PE
Sbjct: 135 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RXMCGTLDYLPPEMIEGKT 189
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++ G+L E + G P D
Sbjct: 190 HDEKVDLWCAGVLCYEFLVGMPPFD 214
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
KV+HRD+K N+L+ + +++DFG + S R + GT Y+ PE
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RXMCGTLDYLPPEMIEGKT 188
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+EK D++ G+L E + G P D
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 8/205 (3%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ T V GT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 331 MLNEKSDVYSFGILIMEIITGRNPV 355
NEKSD++S G L+ E+ P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 41/272 (15%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 63 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 235 DQWLHG-------------------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+L D D PL ++ A+G+A+L
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNC 179
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNE 334
+HRDV + N+LL A++ DFGLA+ + ++ +Y+ ++APE +
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 335 KSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393
+SDV+S+GIL+ EI + G NP + +V S+ + V D PA
Sbjct: 240 QSDVWSYGILLWEIFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF 285
Query: 394 KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
A K + + C + T RP + L+
Sbjct: 286 -APKNIYSIMQACWALEPTHRPTFQQICSFLQ 316
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/239 (25%), Positives = 113/239 (47%), Gaps = 19/239 (7%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 24 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 81
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 82 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
Query: 239 HG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ ++P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 142 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 198
Query: 293 ARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++ DFG+ + + Y + + +++PE G+ SDV+SFG+++ EI T
Sbjct: 199 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+GEG YG VY+ I + G VA+K + +E E+ ++ + ++V+ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ +V EY G+ V D+ LT D I+ T KGL YLH
Sbjct: 95 KNTDLWIVMEYCGAGS--------VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+ +HRD+K+ NILL+ + +A+++DFG+A L + V+GT ++APE
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIGY 202
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
N +D++S GI +E+ G+ P P + ++
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 71 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACTGMLNEK 335
RD+ + N L++ Q +VSDFGL++ + + T+ V F + PE + K
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 336 SDVYSFGILIMEIIT-GRNPVD 356
SD+++FG+L+ EI + G+ P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 32/273 (11%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLH--GDVGDVSP--------LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284
+L V + P L+ ++ A+G+A+L +HRDV + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 285 ILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGI 343
+LL A++ DFGLA+ + ++ +Y+ ++APE + +SDV+S+GI
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 344 LIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLV 402
L+ EI + G NP + +V S+ + V D PA A K + +
Sbjct: 255 LLWEIFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSI 299
Query: 403 ALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
C + T RP + L+ R ER
Sbjct: 300 MQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 75 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACTGMLNEK 335
RD+ + N L++ Q +VSDFGL++ + + T+ V F + PE + K
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 336 SDVYSFGILIMEIIT-GRNPVD 356
SD+++FG+L+ EI + G+ P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ V H ++R+ G + ++ +Y++ G L L +P+ + L
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
L YLH +++RD+K NILLD+ + +++DFG AK + VT + GT
Sbjct: 119 ----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTP 167
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
Y+APE T N+ D +SFGILI E++ G P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 76 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACTGMLNEK 335
RD+ + N L++ Q +VSDFGL++ + + T+ V F + PE + K
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 336 SDVYSFGILIMEIIT-GRNPVD 356
SD+++FG+L+ EI + G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 5 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 65 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YE 180
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTK--VAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G VY+GI + TK VA+K + L ++ + E+ V+ + + R G
Sbjct: 27 IGKGSFGEVYKGI-DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ PL I+ KGL YLH +
Sbjct: 86 YLKSTKLWIIMEYLGGGSA-----LDLLKPGPLEETYIATILREILKGLDYLHSE---RK 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+K++N+LL Q + +++DFG+A L ++ +GT ++APE + K
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 336 SDVYSFGILIMEIITGRNP 354
+D++S GI +E+ G P
Sbjct: 197 ADIWSLGITAIELAKGEPP 215
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 132
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT--FGYVAPEYA 327
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G + APE
Sbjct: 133 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
+ + +SDV+SFG+++ E+ T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I ++ H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ Y GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YE 183
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 23/257 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 17 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 77 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 130
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L E + +GT Y++PE + +S
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW--------LKTMVGSRKSEEVVDPKLP 388
D++S G+ ++E+ GR P P L+D+ L + V S + ++ V+ L
Sbjct: 188 DIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLI 244
Query: 389 KMPASKA-LKRVLLVAL 404
K PA +A LK++++ A
Sbjct: 245 KNPAERADLKQLMVHAF 261
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
+ VIG+G +G+VY G D + A+K+L Q + F E ++ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 211 RLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+G + EG +L+ Y+ +G+L Q++ +P D+ ++ L A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSP--QRNPTVKDL-ISFGLQVARGMEYLA 141
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPE 325
E K VHRD+ + N +LD + +V+DFGLA+ + Y + + A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
T KSDV+SFG+L+ E++T P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YE 184
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD------------VGDVSPLTWDIRMNIIL 258
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HR++ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 199
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + SDV+S+G+L+ EI++
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT--FGYVAPEYA 327
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G + APE
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
+ + +SDV+SFG+++ E+ T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 148 AATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVR 205
+++S + +G G Y VY+G+ + G VA+K + + + + E+ ++ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKG 263
H+N+VRL LV+E++DN +L +++ +P L ++ +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
LA+ HE K++HRD+K N+L++++ ++ DFGLA+ + ++ V+ T Y A
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 324 PEYACTGMLNEKS-DVYSFGILIMEIITGR 352
P+ S D++S G ++ E+ITG+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD------VSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YE 183
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 76 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD 337
RD+ + N L++ Q +VSDFGL++ + + + + PE + KSD
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 338 VYSFGILIMEIIT-GRNPVD 356
+++FG+L+ EI + G+ P +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYE 208
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I ++ H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 219 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 270
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 335 KSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP 346
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 145
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT--FGYVAPEYA 327
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G + APE
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
+ + +SDV+SFG+++ E+ T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 159 IGEGGYGIVYRGIL----SDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IGEG +G + IL DG + +K N+ + +E + EV V+ ++H N+V+
Sbjct: 32 IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
E +V +Y + G+L + ++ G + D ++ + L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVHDR-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
K++HRD+KS NI L + ++ DFG+A++L S + +GT Y++PE
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICENKPY 202
Query: 333 NEKSDVYSFGILIMEIITGRNPVD 356
N KSD+++ G ++ E+ T ++ +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFE 226
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 75.5 bits (184), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCS 306
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + +
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ + + +++PE G+ SDV+SFG+++ EI T
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ Y GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLH-----GDVGDVSP-------LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
+L G +P L+ ++ A+G+A+L +HRDV +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSF 341
N+LL A++ DFGLA+ + ++ +Y+ ++APE + +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 342 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 400
GIL+ EI + G NP + +V S+ + V D PA A K +
Sbjct: 255 GILLWEIFSLGLNP--------------YPGILVNSKFYKLVKDGYQMAQPAF-APKNIY 299
Query: 401 LVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
+ C + T RP + L+ R ER
Sbjct: 300 SIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 334
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 8/205 (3%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ V GT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRM 191
Query: 331 MLNEKSDVYSFGILIMEIITGRNPV 355
NEKSD++S G L+ E+ P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD------VSPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L + ++P +
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E Y
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 181
Query: 312 TTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
G +++PE G+ SDV+SFG+++ EI T
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 10 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L + ++P +
Sbjct: 70 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E Y
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 185
Query: 312 TTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
G +++PE G+ SDV+SFG+++ EI T
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 75.1 bits (183), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + TT
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAKLLCSERSYVT-TRVMGTFGYVAP 324
E +HRD+ + N LL RV+ DFG+A+ + Y M ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ K+D +SFG+L+ EI +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 75 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
E VHRD+ + N+LL Q A++SDFGL+K L ++ + + G + + APE
Sbjct: 128 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 2 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 62 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N + + ++ DFG+ + + E
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDI-YE 177
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G +++PE G+ SDV+SFG+++ EI T
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 142 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 193
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 335 KSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 250 EVDIWSLGIMVIEMVDGEPP 269
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD------VSPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L + ++P +
Sbjct: 64 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSY 310
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + ++
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ + +++PE G+ SDV+SFG+++ EI T
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 68/249 (27%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 75 LKDTKLWIIMEYLGGGS-----ALDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+K++N+LL +++DFG+A L + T V GT ++APE + K+
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 185
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMPA 392
D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K P+
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 245
Query: 393 SKALKRVLL 401
+ + LL
Sbjct: 246 FRPTAKELL 254
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVA 323
YL+ K VHRD+ + N ++ + ++ DFG+ + + E +Y G ++A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRWMA 200
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT 350
PE G+ SD++SFG+++ EI +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 82/298 (27%), Positives = 139/298 (46%), Gaps = 32/298 (10%)
Query: 159 IGEGGYGIVYRGIL---SDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 213 LGYCVEG--AYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + A LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEY 326
+HRD+ + N+LLD ++ DFGLAK + R G F Y APE
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APEC 208
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD-- 384
SDV+SFG+ + E++T + S P + L+ + + + E+++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQ-SPPTKFLELIGIAQGQMTVLRLTELLERG 267
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPS 442
+LP+ K V + C + +A+ RP ++I +L+ E+ G+ PS
Sbjct: 268 ERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT-----VHEKYQGQAPS 318
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 97 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 148
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 335 KSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 205 EVDIWSLGIMVIEMVDGEPP 224
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 99 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 150
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 335 KSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 207 EVDIWSLGIMVIEMVDGEPP 226
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/258 (24%), Positives = 118/258 (45%), Gaps = 31/258 (12%)
Query: 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
E +IG GG+G V++ DG +K + N +AE+E V+ + ++ H N+V
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYN 70
Query: 214 GYCVEG-----------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
G C +G + E+ D G L+QW+ G+ L + + +
Sbjct: 71 G-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALEL 127
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
KG+ Y+H K+++RD+K SNI L ++ DFGL L ++ R
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RXRSK 182
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
GT Y++PE + ++ D+Y+ G+++ E++ + + + +L D + + +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-FETSKFFTDLRDGIISDIFD 241
Query: 377 RKSEEVVDPKLPKMPASK 394
+K + ++ L K P +
Sbjct: 242 KKEKTLLQKLLSKKPEDR 259
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L L+ ++
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 45/290 (15%)
Query: 162 GGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVE 218
G +G V++ +++D V + L Q ++ ++ E E+ ++H+NL++ +
Sbjct: 26 GRFGCVWKAQLMNDFVAVKIFPL-----QDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 219 GA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE----- 269
G+ L+ + D G+L +L G++ +TW+ ++ ++GL+YLHE
Sbjct: 81 GSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 270 ---GLEPKVVHRDVKSSNILLDRQWNARVSDFGLA-KLLCSERSYVTTRVMGTFGYVAPE 325
G +P + HRD KS N+LL A ++DFGLA + + T +GT Y+APE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 326 YACTGMLNEKS------DVYSFGILIMEIIT----GRNPVD-----YSRPQGEVNLVDWL 370
G +N + D+Y+ G+++ E+++ PVD + G+ ++ L
Sbjct: 196 -VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEEL 254
Query: 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420
+ +V +K + K P L ++ + C D DA R G V
Sbjct: 255 QEVVVHKKMRPTIKDHWLKHP---GLAQLCVTIEECWDHDAEARLSAGCV 301
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 337 DVYSFGILIMEIITGRNPV-------DYSRPQGEVNLVDW--------LKTMVGSRKSEE 381
D++S G+ ++E+ GR P+ D P L+D+ L + V S + ++
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 244
Query: 382 VVDPKLPKMPASKA-LKRVLLVAL 404
V+ L K PA +A LK++++ A
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAF 268
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 92 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 143
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ D++S GI+++E++ G P P + ++
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVA 323
YL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G ++A
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 199
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT 350
PE G+ SD++SFG+++ EI +
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS 226
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH-----GDVGDVSP-------LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L G +P L+ ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 139
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLNE 334
RD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ D++S GI+++E++ G P P + ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/249 (27%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 35 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 95 LKDTKLWIIMEYLGGGS-----ALDLLEPGPLDETQIATILREILKGLDYLHS---EKKI 146
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+K++N+LL +++DFG+A L + T V GT ++APE + K+
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 205
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMPA 392
D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K P+
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 265
Query: 393 SKALKRVLL 401
+ + LL
Sbjct: 266 FRPTAKELL 274
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVA 323
YL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G ++A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 200
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT 350
PE G+ SD++SFG+++ EI +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L L+ ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 8/205 (3%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
V+HRD+K +N+ LD + N ++ DFGLA++L + + V GT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRM 191
Query: 331 MLNEKSDVYSFGILIMEIITGRNPV 355
NEKSD++S G L+ E+ P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 90 LKDTKLWIIMEYLGGGSA-----LDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 141
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+K++N+LL +++DFG+A L ++ +GT ++APE + K+
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMPA 392
D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K P+
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 260
Query: 393 SKALKRVLL 401
+ + LL
Sbjct: 261 FRPTAKELL 269
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 159 IGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V + G +VAVK+L G + K E+E++ + H+N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 213 LGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C E G L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN---LKQQLKYAVQICKGMDYLGSR 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYVAPEYA 327
+ VHRD+ + N+L++ + ++ DFGL K + +++ T R F Y APE
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
SDV+SFG+ + E++T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP--------LTWDIRMNIILGTA 261
LLG C + G M++ E+ GNL +L + P LT + + A
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFG 320
KG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 27/282 (9%)
Query: 159 IGEGGYGIVYRGIL---SDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + + LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHS 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEY 326
+HR++ + N+LLD ++ DFGLAK + Y R G F Y APE
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD-- 384
SDV+SFG+ + E++T + S P + L+ + + + E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQ-SPPTKFLELIGIAQGQMTVLRLTELLERG 250
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+LP+ K V + C + +A+ RP ++I +L+
Sbjct: 251 ERLPR--PDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 17/224 (7%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------P 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCS 306
T + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ + + ++APE G+ SD++SFG+++ EI +
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTTRVMGTFGYVAP 324
YL+ K VHRD+ + N ++ + ++ DFG+ + + ++ + + ++AP
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ SD++SFG+++ EI +
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITS 224
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTTRVMGTFGYVAP 324
YL+ K VHRD+ + N ++ + ++ DFG+ + + ++ + + ++AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT 350
E G+ SD++SFG+++ EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 27/282 (9%)
Query: 159 IGEGGYGIVYRGIL---SDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + + LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEY 326
+HR++ + N+LLD ++ DFGLAK + Y R G F Y APE
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD-- 384
SDV+SFG+ + E++T + S P + L+ + + + E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQ-SPPTKFLELIGIAQGQMTVLRLTELLERG 250
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+LP+ K V + C + +A+ RP ++I +L+
Sbjct: 251 ERLPR--PDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 75 LKDTKLWIIMEYLGGGS-----ALDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+K++N+LL +++DFG+A L ++ +GT ++APE + K+
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMPA 392
D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K P+
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 245
Query: 393 SKALKRVLL 401
+ + LL
Sbjct: 246 FRPTAKELL 254
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 157 NVIGEGGYGIV--YRGILSDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVR 211
IG G YG+V R L+ G +VA+K + N A++ + E++++ +H N++
Sbjct: 61 ETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIA 118
Query: 212 L---LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ L V VY +D D LH + PLT + + +GL Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFGYVAPE 325
+V+HRD+K SN+L++ ++ DFG+A+ LC+ E Y T + T Y APE
Sbjct: 177 SA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 326 YACTGMLNEKS---DVYSFGILIMEIITGRN 353
+ L+E + D++S G + E++ R
Sbjct: 234 LMLS--LHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 159 IGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V + G +VAVK+L G + K E+E++ + H+N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 213 LGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C E G L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN---LKQQLKYAVQICKGMDYLGSR 133
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYVAPEYA 327
+ VHRD+ + N+L++ + ++ DFGL K + +++ T R F Y APE
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
SDV+SFG+ + E++T
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP--------LTWDIRMNIILGTA 261
LLG C + G M++ E+ GNL +L + P LT + + A
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFG 320
KG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 63/271 (23%), Positives = 119/271 (43%), Gaps = 44/271 (16%)
Query: 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
E +IG GG+G V++ DG ++ + N +AE+E V+ + ++ H N+V
Sbjct: 16 EIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYN 71
Query: 214 GYCVEG------------------------------AYRMLVYEYVDNGNLDQWLHGDVG 243
G C +G + E+ D G L+QW+ G
Sbjct: 72 G-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+ L + + + KG+ Y+H K++HRD+K SNI L ++ DFGL
Sbjct: 131 E--KLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363
L ++ TR GT Y++PE + ++ D+Y+ G+++ E++ + + +
Sbjct: 186 LKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-FETSKFF 242
Query: 364 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
+L D + + + +K + ++ L K P +
Sbjct: 243 TDLRDGIISDIFDKKEKTLLQKLLSKKPEDR 273
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ + G E + + E+E+ + H N++RL
Sbjct: 31 LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG-VEHQLRREIEIQAHLHHPNILRLY 89
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGL 271
Y + L+ EY G L + L T+D + I+ A L Y H
Sbjct: 90 NYFYDRRRIYLILEYAPRGELYKELQKSC------TFDEQRTATIMEELADALMYCHGK- 142
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
KV+HRD+K N+LL + +++DFG + S R + GT Y+ PE M
Sbjct: 143 --KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR---KTMCGTLDYLPPEMIEGRM 197
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
NEK D++ G+L E++ G P +
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFE 222
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V L+ G L+ EY+ G L L + D + + L +LH+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+++RD+K NI+L+ Q + +++DFGL K + + VT GT Y+APE
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMR 195
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPV 355
N D +S G L+ +++TG P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPF 221
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 72.8 bits (177), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT--FGYVAPEYA 327
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ R G + APE
Sbjct: 130 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
+ + +SDV+SFG+++ E+ T
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 72.8 bits (177), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + + T + ++ A G+ YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT---LLQMVGDAAAGMEYLESKC---CI 235
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG----TFGYVAPEYACTGML 332
HRD+ + N L+ + ++SDFG+++ E V G + APE G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
+ +SDV+SFGIL+ E + G +P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V L+ G L+ EY+ G L L + D + + L +LH+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+++RD+K NI+L+ Q + +++DFGL K + + VT GT Y+APE
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMR 195
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPV 355
N D +S G L+ +++TG P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPF 221
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL- 212
IG G YG+V R L+ G +VA+K N + A++ + E++++ +H N++ +
Sbjct: 62 IGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIK 119
Query: 213 --LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L V VY +D D LH + PLT + + +GL Y+H
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 177
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFGYVAPEYA 327
+V+HRD+K SN+L++ ++ DFG+A+ LC+ E Y T + T Y APE
Sbjct: 178 ---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 328 CTGMLNEKS---DVYSFGILIMEIITGRN 353
+ L+E + D++S G + E++ R
Sbjct: 235 LS--LHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGMLNE 334
HRD+K N+L++R+ +++DFGLA+ R Y T + T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYST 180
Query: 335 KSDVYSFGILIMEIITG 351
D++S G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + + T + ++ A G+ YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT---LLQMVGDAAAGMEYLESKC---CI 235
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG----TFGYVAPEYACTGML 332
HRD+ + N L+ + ++SDFG+++ E V G + APE G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
+ +SDV+SFGIL+ E + G +P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGMLNE 334
HRD+K N+L++R+ +++DFGLA+ R Y T + T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYST 180
Query: 335 KSDVYSFGILIMEIITG 351
D++S G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 72.0 bits (175), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 68/262 (25%), Positives = 120/262 (45%), Gaps = 27/262 (10%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
++G G YG VY+G ++A +++ G E+E K E+ ++ + H+N+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 217 VE------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ LV E+ G++ + G+ W I +GL++LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQH 148
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YAC- 328
KV+HRD+K N+LL ++ DFG++ L T +GT ++APE AC
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 204
Query: 329 ---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-----DWLKTMVGSRKSE 380
+ KSD++S GI +E+ G P+ P + L+ LK+ S+K +
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 264
Query: 381 EVVDPKLPK----MPASKALKR 398
++ L K PA++ L +
Sbjct: 265 SFIESCLVKNHSQRPATEQLMK 286
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 72.0 bits (175), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------P 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
T + + A G+AYL+ K VHR++ + N ++ + ++ DFG+ + + E
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YE 182
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G ++APE G+ SD++SFG+++ EI +
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGMLNE 334
HRD+K N+L++R+ +++DFGLA+ R Y T + T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYST 180
Query: 335 KSDVYSFGILIMEIITG 351
D++S G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ H N+V + +
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+YLH V+H
Sbjct: 113 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 164
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYVAPEYACTGMLNEK 335
RD+KS +ILL ++SDFG + E V R ++GT ++APE +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 336 SDVYSFGILIMEIITGRNP 354
D++S GI+++E+I G P
Sbjct: 222 VDIWSLGIMVIEMIDGEPP 240
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 8 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------P 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 68 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
T + + A G+AYL+ K VHR++ + N ++ + ++ DFG+ + + E
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YE 183
Query: 308 RSYVTTRVMGTFG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y G ++APE G+ SD++SFG+++ EI +
Sbjct: 184 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 66/227 (29%), Positives = 113/227 (49%), Gaps = 33/227 (14%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V G +G V++ L + VAVK + ++ + E+ EV + ++H+N+++ +G
Sbjct: 31 VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAE 87
Query: 217 VEGAY----RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE--- 269
G L+ + + G+L +L +V ++W+ +I A+GLAYLHE
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIP 142
Query: 270 ----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLA-KLLCSERSYVTTRVMGTFGYVAP 324
G +P + HRD+KS N+LL A ++DFGLA K + + T +GT Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 325 EYACTGMLNEKS------DVYSFGILIMEIIT----GRNPVD-YSRP 360
E G +N + D+Y+ G+++ E+ + PVD Y P
Sbjct: 203 E-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G+G +G VY+ + +A ++ + + E E + VE+E++ H +V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 218 EGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E+ G +D L D G P + ++ + L +LH +++
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTFGYVAPEYA-CTGM 331
HRD+K+ N+L+ + + R++DFG++ K L S++ GT ++APE C M
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETM 194
Query: 332 ----LNEKSDVYSFGILIMEIITGRNP 354
+ K+D++S GI ++E+ P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 21/258 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 33 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 93 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 146
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 203
Query: 337 DVYSFGILIMEIITGRNPVDY-SRPQGEVNLVDW--------LKTMVGSRKSEEVVDPKL 387
D++S G+ ++E+ GR P+ S L+D+ L + V S + ++ V+ L
Sbjct: 204 DIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 263
Query: 388 PKMPASKA-LKRVLLVAL 404
K PA +A LK++++ A
Sbjct: 264 IKNPAERADLKQLMVHAF 281
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+VD +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEHVDQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 185 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 393 SK 394
K
Sbjct: 240 YK 241
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G+G +G VY+ + +A ++ + + E E + VE+E++ H +V+LLG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 218 EGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E+ G +D L D G P + ++ + L +LH +++
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTFGYVAPEYA-CTGM 331
HRD+K+ N+L+ + + R++DFG++ K L S++ GT ++APE C M
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETM 186
Query: 332 ----LNEKSDVYSFGILIMEIITGRNP 354
+ K+D++S GI ++E+ P
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPP 213
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 31/224 (13%)
Query: 132 VSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE 191
+S LG G + +++ SGL I+ R ++ K A++N
Sbjct: 21 ISELGAGNGGVVTKVQHRPSGL------------IMARKLIHLEIKPAIRN--------- 59
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ E++V+ +V G + E++D G+LDQ L + + +
Sbjct: 60 -QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----EAKRIPEE 114
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
I + + +GLAYL E + +++HRDVK SNIL++ + ++ DFG++ L +
Sbjct: 115 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 169
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
+GT Y+APE + +SD++S G+ ++E+ GR P+
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRT 228
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 35/285 (12%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEGG+ V G L DG A+K +L + Q +E + E ++ H N++RL+ YC
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 217 V--EGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ GA L+ + G L + + LT D + ++LG +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC----SERSYVTTRVMG----TFGYVAP 324
HRD+K +NILL + + D G C R +T + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 325 EYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
E +++E++DV+S G ++ ++ G P D +G D + V ++ S
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-----DSVALAVQNQLS-- 265
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+P+ P + LL ++ VDP +RP + ++ LEA
Sbjct: 266 -----IPQSPRHSSALWQLLNSMMTVDPH--QRPHIPLLLSQLEA 303
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQA--EKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V++ D G VA+K L + +K E+ ++ +++H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 216 CVEGAYRMLVYEYVDNG---NLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV+EY D+ LD++ G V +TW T + + + H+
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TG 330
+HRDVK NIL+ + ++ DFG A+LL Y V T Y +PE
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDT 178
Query: 331 MLNEKSDVYSFGILIMEIITG 351
DV++ G + E+++G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG 199
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRT 228
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRT 228
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG GIV G +VAVK +++ R Q +E EV ++ +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G ++ E++ G L D+ L + + + LAYLH V+
Sbjct: 112 LVGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVI 163
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLN 333
HRD+KS +ILL ++SDFG C++ S + ++GT ++APE +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 334 EKSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNA 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 158 VIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ + + VAVK + KE F E ++ + H ++V+L
Sbjct: 31 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 91 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+ NIL+ ++ DFGL++ + E Y + +++PE
Sbjct: 145 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL--KTMVGSRKSEEVVDPKLPK 389
SDV+ F + + EI++ G+ P WL K ++G + + +LPK
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGD----RLPK 247
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
+ L+ RC D D + RP+ ++ L +++ E+ I E
Sbjct: 248 PDLCPPVLYTLMT--RCWDYDPSDRPRFTELVCSLSD---VYQMEKDIAME 293
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-F 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E E +
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ T L YLH+ K++HRD+K+ NIL + +++DFG++ ++ +
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQ 190
Query: 314 R---VMGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEIITGRNP 354
R +GT ++APE + K+DV+S GI ++E+ P
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 158 VIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ + + VAVK + KE F E ++ + H ++V+L
Sbjct: 15 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 75 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 128
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+ NIL+ ++ DFGL++ + E Y + +++PE
Sbjct: 129 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL--KTMVGSRKSEEVVDPKLPK 389
SDV+ F + + EI++ G+ P WL K ++G + + +LPK
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGD----RLPK 231
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
+ L+ RC D D + RP+ ++ L +++ E+ I E
Sbjct: 232 PDLCPPVLYTLMT--RCWDYDPSDRPRFTELVCSLSD---VYQMEKDIAME 277
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 158 VIGE-GGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL-G 214
+IGE G +G VY+ + + +A +++ + + E E + VE++++ H N+V+LL
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 75
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ E +L+ E+ G +D + + PLT + T L YLH+ K
Sbjct: 76 FYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---K 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYVAPEYACTGM- 331
++HRD+K+ NIL + +++DFG++ + R+ + R +GT ++APE
Sbjct: 129 IIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTXIQRRDSFIGTPYWMAPEVVMCETS 186
Query: 332 ----LNEKSDVYSFGILIMEIITGRNP 354
+ K+DV+S GI ++E+ P
Sbjct: 187 KDRPYDYKADVWSLGITLIEMAEIEPP 213
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 159 IGEGGYGIVYR----GILSDGTK--VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP----------LTWDIRMNIILG 259
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGT 318
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 158 VIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ + + VAVK + KE F E ++ + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 79 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 132
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+ NIL+ ++ DFGL++ + E Y + +++PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL--KTMVGSRKSEEVVDPKLPK 389
SDV+ F + + EI++ G+ P WL K ++G + + +LPK
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGD----RLPK 235
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
+ L+ RC D D + RP+ ++ L +++ E+ I E
Sbjct: 236 PDLCPPVLYTLMT--RCWDYDPSDRPRFTELVCSLSD---VYQMEKDIAME 281
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G K+AVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 118 VFTPATS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 226
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N D++S G ++ E++TGR
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRT 250
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 68/245 (27%), Positives = 116/245 (47%), Gaps = 26/245 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG V++ + + VA+K + ++ G + E+ ++ ++HKN+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+ D +L ++ GD+ P +I + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCHSR---N 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
V+HRD+K N+L++R +++DFGLA+ R Y V T Y P+ L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 179
Query: 334 EKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK---TMVGSRKSEEVVDPKLPK 389
S D++S G + E+ P+ P +V+ D LK ++G+ E+ P + K
Sbjct: 180 STSIDMWSAGCIFAELANAARPL---FPGNDVD--DQLKRIFRLLGTPTEEQW--PSMTK 232
Query: 390 MPASK 394
+P K
Sbjct: 233 LPDYK 237
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-F 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E E +
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ T L YLH+ K++HRD+K+ NIL + +++DFG++ ++ +
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQ 190
Query: 314 R---VMGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEIITGRNP 354
R +GT ++APE + K+DV+S GI ++E+ P
Sbjct: 191 RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 70/304 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 200 VIGRVRHKNLVRLLGYCVE-------------GAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H+ +VR +E + + EY +NG L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
W + I+ + L+Y+H ++HRD+K NI +D N ++ DFGLAK +
Sbjct: 115 RDEYWRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 306 SERSYVT-------------TRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITG 351
+ T +GT YVA E TG NEK D+YS GI+ E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-- 225
Query: 352 RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
+S VN++ L+++ E D KM K + R+L +D D
Sbjct: 226 ---YPFSTGMERVNILKKLRSV----SIEFPPDFDDNKMKVEKKIIRLL------IDHDP 272
Query: 412 TKRP 415
KRP
Sbjct: 273 NKRP 276
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP-----------LTWDIRMNIIL 258
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMG 317
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYC 216
IG+G YG V+ G G KVAVK E + E E+ V RH+N++ +
Sbjct: 45 IGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 217 VEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL- 271
++G L+ +Y +NG+L +L D + + + + GL +LH +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTEIF 155
Query: 272 ----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV----TTRVMGTFGYVA 323
+P + HRD+KS NIL+ + ++D GLA S+ + V TRV GT Y+
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMP 214
Query: 324 PEYACTGMLNEK-------SDVYSFGILIMEI 348
PE LN +D+YSFG+++ E+
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-F 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E E +
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ T L YLH+ K++HRD+K+ NIL + +++DFG++ ++ +
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQ 190
Query: 314 R---VMGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEIITGRNP 354
R +GT ++APE + K+DV+S GI ++E+ P
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 15 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 74 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 127
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 185
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 238
Query: 391 PASK 394
P K
Sbjct: 239 PDYK 242
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 38/269 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 --VFTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 331 M-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
M N+ D++S G ++ E++TGR + +D LK ++ +L
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLF------PGTDHIDQLKLIL-----------RLVG 246
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMG 418
P ++ LK++ + R T+ PKM
Sbjct: 247 TPGAELLKKISSESARNYIQSLTQMPKMN 275
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGIL---SDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L G Q ++ E+E++ + H+++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C + + LV EYV G+L +L ++ L + +G+AYLH
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYA 327
+HR + + N+LLD ++ DFGLAK + Y R G F Y APE
Sbjct: 132 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECL 187
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
SDV+SFG+ + E++T
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 182
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 235
Query: 391 PASK 394
P K
Sbjct: 236 PDYK 239
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 18 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 77 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 130
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGXKYY 188
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 241
Query: 391 PASK 394
P K
Sbjct: 242 PDYK 245
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 180
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 233
Query: 391 PASK 394
P K
Sbjct: 234 PDYK 237
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 18 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 77 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 130
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 188
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 241
Query: 391 PASK 394
P K
Sbjct: 242 PDYK 245
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGIL---SDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L G Q ++ E+E++ + H+++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C + + LV EYV G+L +L ++ L + +G+AYLH
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYA 327
+HR + + N+LLD ++ DFGLAK + Y R G F Y APE
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECL 186
Query: 328 CTGMLNEKSDVYSFGILIMEIIT 350
SDV+SFG+ + E++T
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY + + VA+K + + Q+ ++++ EV + ++RH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV--SPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV EY D+ +V PL + G +GLAYLH
Sbjct: 122 CYLREHTAWLVMEYCLGSA------SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
++HRDVK+ NILL ++ DFG A ++ +V GT ++APE
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDE 227
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-----NLVDWLKTMVGSRKSEEVVD 384
G + K DV+S GI +E+ + P+ + N L++ S VD
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287
Query: 385 PKLPKMPASKALKRVLL---VALRCVDP----DATKRPKMGHVIHMLEADDLLFRDERRI 437
L K+P + VLL LR P D +R K + E D+L +R ++I
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA----VRELDNLQYRKMKKI 343
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGXKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 76 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 189
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 246
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 247 DIWSMGLSLVEMAVGRYPI 265
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 38/269 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 331 M-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
M N+ D++S G ++ E++TGR + +D LK ++ +L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF------PGTDHIDQLKLIL-----------RLVG 242
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMG 418
P ++ LK++ + R T+ PKM
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMN 271
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 180
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 233
Query: 391 PASK 394
P K
Sbjct: 234 PDYK 237
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 112 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 220
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRT 244
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ + LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 68/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+V + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEHV-HQDLKTFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 180
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 233
Query: 391 PASK 394
P K
Sbjct: 234 PDYK 237
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRT 223
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 --VFTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRT 233
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRT 233
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRT 233
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 204
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRT 228
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN 255
E+ ++ + H N+++L + Y LV E+ + G L +Q ++ D N
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----N 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERSYVT 312
I+ G+ YLH+ +VHRD+K NILL+ + N ++ DFGL+ + Y
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKL 205
Query: 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
+GT Y+APE NEK DV+S G+++ ++ G P
Sbjct: 206 RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 100 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRT 232
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVM 316
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + V
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 88 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 196
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRT 220
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRT 223
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 108 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRT 240
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 68/221 (30%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLL- 213
+IG G YG VY+G L D VAVK A ++ + + I RV H N+ R +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 214 -GYCVEGAYRM---LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V RM LV EY NG+L ++L D W + +GLAYLH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHT 129
Query: 270 GL------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-------SYVTTRVM 316
L +P + HRD+ S N+L+ +SDFGL+ L R +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 317 GTFGYVAPEYACTGMLN--------EKSDVYSFGILIMEII 349
GT Y+APE G +N ++ D+Y+ G++ EI
Sbjct: 190 GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRT 241
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY + + VA+K + + Q+ ++++ EV + ++RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV--SPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV EY D+ +V PL + G +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSA------SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
++HRDVK+ NILL ++ DFG A ++ +V GT ++APE
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDE 188
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-----NLVDWLKTMVGSRKSEEVVD 384
G + K DV+S GI +E+ + P+ + N L++ S VD
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 385 PKLPKMPASKALKRVLL---VALRCVDP----DATKRPKMGHVIHMLEADDLLFRDERRI 437
L K+P + VLL LR P D +R K + E D+L +R ++I
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA----VRELDNLQYRKMKKI 304
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 108 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRT 240
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 68.9 bits (167), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRT 241
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 68.9 bits (167), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 100 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRT 232
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 86 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRT 218
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 87 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 195
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRT 219
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 86 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRT 218
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 42/291 (14%)
Query: 159 IGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLV 210
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+V
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------NI 256
LLG C G +++ EY G+L +L SP + +
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RV 315
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 167 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374
++APE + +SDV+S+GI + E+ + G +P M
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 268
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 99 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 154
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 207
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRT 231
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 151 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 42/291 (14%)
Query: 159 IGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLV 210
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+V
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------NI 256
LLG C G +++ EY G+L +L SP + +
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RV 315
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374
++APE + +SDV+S+GI + E+ + G +P M
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 275
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 38/269 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 331 M-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
M N+ D++S G ++ E++TGR + +D LK ++ +L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF------PGTDHIDQLKLIL-----------RLVG 242
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMG 418
P ++ LK++ + R T+ PKM
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMN 271
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 236
Query: 391 PASK 394
P K
Sbjct: 237 PDYK 240
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 42/291 (14%)
Query: 159 IGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLV 210
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------NI 256
LLG C G +++ EY G+L +L SP + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RV 315
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374
++APE + +SDV+S+GI + E+ + G +P P V+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD--------- 254
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 255 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 154
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 212 DIWSMGLSLVEMAVGRYPI 230
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 28/265 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
+G G YG+V + + G +AVK + Q +K +++++ R V V G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ E +D +LD++ + + DI I + K L +LH L V
Sbjct: 119 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE- 334
+HRDVK SN+L++ ++ DFG++ L S T G Y+APE LN+
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVD--SVAKTIDAGCKPYMAPE-RINPELNQK 232
Query: 335 ----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
KSD++S GI ++E+ R P D W ++ ++VV+ P++
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPF---QQLKQVVEEPSPQL 278
Query: 391 PASKALKRVLLVALRCVDPDATKRP 415
PA K + +C+ ++ +RP
Sbjct: 279 PADKFSAEFVDFTSQCLKKNSKERP 303
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 235
Query: 391 PASK 394
P K
Sbjct: 236 PDYK 239
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 68.6 bits (166), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 237
Query: 391 PASK 394
P K
Sbjct: 238 PDYK 241
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 68.6 bits (166), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 236
Query: 391 PASK 394
P K
Sbjct: 237 PDYK 240
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 236
Query: 391 PASK 394
P K
Sbjct: 237 PDYK 240
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 152 GLCEENVIGEGGYG-IVYRGILSDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNL 209
C ++V+G G G IVYRG+ D VAVK +L A++E ++ E H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRE---SDEHPNV 80
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+R +C E R Y ++ + + D + L + + ++ T GLA+LH
Sbjct: 81 IRY--FCTEKD-RQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHS 136
Query: 270 GLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYV 322
+VHRD+K NIL+ + A +SDFGL K L R + R V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 323 APEYA---CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYS-RPQGEVNLVDWLKTMVGSR 377
APE C D++S G + +I+ G +P S + Q + L +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
K E+V+ R L+ + +DP KRP HV+
Sbjct: 254 KHEDVI-------------ARELIEKMIAMDPQ--KRPSAKHVL 282
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 237
Query: 391 PASK 394
P K
Sbjct: 238 PDYK 241
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 235
Query: 391 PASK 394
P K
Sbjct: 236 PDYK 239
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 183 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 393 SK 394
K
Sbjct: 238 YK 239
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 393 SK 394
K
Sbjct: 237 YK 238
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 180
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 233
Query: 391 PASK 394
P K
Sbjct: 234 PDYK 237
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 15 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 74 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 127
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 185
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 238
Query: 391 PASK 394
P K
Sbjct: 239 PDYK 242
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 109/241 (45%), Gaps = 21/241 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGY 215
IG G + VY+G+ ++ T L +R + E FK E E + ++H N+VR
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 216 ---CVEGAYRM-LVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
V+G + LV E +G L +L V + L R + KGL +LH
Sbjct: 94 WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL-----KGLQFLHTR 148
Query: 271 LEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
P ++HRD+K NI + + ++ D GLA L +R+ V+GT + APE
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXY-E 203
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+E DVY+FG +E T P YS Q + + + V ++V P++ +
Sbjct: 204 EKYDESVDVYAFGXCXLEXATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 390 M 390
+
Sbjct: 262 I 262
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 42/291 (14%)
Query: 159 IGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLV 210
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+V
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------NI 256
LLG C G +++ EY G+L +L SP + +
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RV 315
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374
++APE + +SDV+S+GI + E+ + G +P M
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 275
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 55 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
K+VHRD+K N+LL+ + N R+ DFGL+ E S +GT Y+APE
Sbjct: 169 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPE- 222
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
G +EK DV+S G+++ +++G P +
Sbjct: 223 VLHGTYDEKCDVWSTGVILYILLSGCPPFN 252
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 180
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 233
Query: 391 PASK 394
P K
Sbjct: 234 PDYK 237
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVR 211
IGEG YG V+ R + + G VA+K + G+ EV V+ + H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 212 LLGYCVEG-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L C LV+E+VD +L +L V + T I+ +++ +GL +
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIK-DMMFQLLRGLDF 135
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
LH +VVHRD+K NIL+ +++DFGLA++ + + T V+ T Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEV 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPV 355
D++S G + E+ R P+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 54 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
K+VHRD+K N+LL+ + N R+ DFGL+ E S +GT Y+APE
Sbjct: 168 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPE- 221
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
G +EK DV+S G+++ +++G P +
Sbjct: 222 VLHGTYDEKCDVWSTGVILYILLSGCPPFN 251
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 66/244 (27%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GL++ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLSFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 234
Query: 391 PASK 394
P K
Sbjct: 235 PDYK 238
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 42/291 (14%)
Query: 159 IGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLV 210
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+V
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------NI 256
LLG C G +++ EY G+L +L SP + +
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RV 315
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 169 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374
++APE + +SDV+S+GI + E+ + G +P P V+
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD--------- 272
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 273 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + K E++ + RH +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+L +V EYV G L ++ HG V ++ + + Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQILSAVDYCH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ VVHRD+K N+LLD NA+++DFGL+ ++ S+ ++ T G+ Y APE
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPE-VI 182
Query: 329 TGML--NEKSDVYSFGILIMEIITGRNPVD 356
+G L + D++S G+++ ++ G P D
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
K+VHRD+K N+LL+ + N R+ DFGL+ E S +GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPE- 198
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
G +EK DV+S G+++ +++G P +
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 237
Query: 391 PASK 394
P K
Sbjct: 238 PDYK 241
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 38/269 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 112 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E YV TR Y APE
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNW 220
Query: 331 M-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
M N+ D++S G ++ E++TGR + +D LK ++ +L
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLF------PGTDHIDQLKLIL-----------RLVG 263
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMG 418
P ++ LK++ + R T+ PKM
Sbjct: 264 TPGAELLKKISSESARNYIQSLTQMPKMN 292
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 37 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 95 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
K+VHRD+K N+LL+ + N R+ DFGL+ E S +GT Y+APE
Sbjct: 151 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPE- 204
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
G +EK DV+S G+++ +++G P +
Sbjct: 205 VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKTFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 185 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 393 SK 394
K
Sbjct: 240 YK 241
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 337 DVYSFGILIMEIITGRNPV 355
D++S G+ ++E+ GR P+
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 118/243 (48%), Gaps = 22/243 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG+VY R L+ K L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+E++ + +L +++ D ++ + + + + +GLA+ H +V
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGMLN 333
+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYS 182
Query: 334 EKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
D++S G + E++T R P D E++ + + +G+ +EVV P + MP
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSMP 235
Query: 392 ASK 394
K
Sbjct: 236 DYK 238
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 118/243 (48%), Gaps = 22/243 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG+VY R L+ K L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+E++ + +L +++ D ++ + + + + +GLA+ H +V
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGMLN 333
+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYS 181
Query: 334 EKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
D++S G + E++T R P D E++ + + +G+ +EVV P + MP
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSMP 234
Query: 392 ASK 394
K
Sbjct: 235 DYK 237
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 393 SK 394
K
Sbjct: 237 YK 238
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 333 NEKSDVYSFGILIMEIITGRN--PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ D++S G + E++T R P D E++ + + +G+ +EVV P + M
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGT--PDEVVWPGVTSM 235
Query: 391 PASK 394
P K
Sbjct: 236 PDYK 239
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ D+GLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 185 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 393 SK 394
K
Sbjct: 240 YK 241
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 152 GLCEENV-------IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV--EVEV 200
GLC + IGEG YG V+ R + + G VA+K + G+ EV V
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64
Query: 201 IGRVR---HKNLVRLLGYCVEG-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252
+ + H N+VRL C LV+E+VD +L +L V + T I
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETI 122
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
+ +++ +GL +LH +VVHRD+K NIL+ +++DFGLA++ + +
Sbjct: 123 K-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
T V+ T Y APE D++S G + E+ R P+
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVR 211
IGEG YG V+ R + + G VA+K + G+ EV V+ + H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 212 LLGYCVEG-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L C LV+E+VD +L +L V + T I+ +++ +GL +
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIK-DMMFQLLRGLDF 135
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
LH +VVHRD+K NIL+ +++DFGLA++ + + T V+ T Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEV 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPV 355
D++S G + E+ R P+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TGML 332
V+HRD+K N+L++ + +++DFGLA+ R+Y V T Y APE
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+ D++S G + E++T R + G+ + + +EVV P + MP
Sbjct: 184 STAVDIWSLGCIFAEMVTRR-----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 393 SK 394
K
Sbjct: 239 YK 240
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYLHEGLE 272
LV+E+++ +L + L + + D ++ I L +G+A+ H+
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TG 330
+++HRD+K N+L++ +++DFGLA+ RSY T + T Y AP+ +
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK 195
Query: 331 MLNEKSDVYSFGILIMEIITGR 352
+ D++S G + E+ITG+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR Y APE
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNW 193
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 116/245 (47%), Gaps = 26/245 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG V++ + + VA+K + ++ G + E+ ++ ++HKN+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+ D +L ++ GD+ P +I + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCHSR---N 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
V+HRD+K N+L++R ++++FGLA+ R Y V T Y P+ L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 179
Query: 334 EKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK---TMVGSRKSEEVVDPKLPK 389
S D++S G + E+ P+ P +V+ D LK ++G+ E+ P + K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL---FPGNDVD--DQLKRIFRLLGTPTEEQW--PSMTK 232
Query: 390 MPASK 394
+P K
Sbjct: 233 LPDYK 237
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYLHEGLE 272
LV+E+++ +L + L + + D ++ I L +G+A+ H+
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC-TG 330
+++HRD+K N+L++ +++DFGLA+ RSY T + T Y AP+ +
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK 195
Query: 331 MLNEKSDVYSFGILIMEIITGR 352
+ D++S G + E+ITG+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 43 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 211 RLLGYCVEGAYRMLV-YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH- 268
+L +C + ++ Y NG L +++ +G I+ L YLH
Sbjct: 101 KLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHG 155
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYA 327
+G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 156 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 212 TEKSACKSSDLWALGCIIYQLVAGLPPF 239
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGL + E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++HRD+K SN+ ++ ++ DFGLA+ E T + T Y APE M
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWM 198
Query: 332 -LNEKSDVYSFGILIMEIITGRN 353
N+ D++S G ++ E++TGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 70/304 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 200 VIGRVRHKNLVRLLGYCVE-------------GAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H+ +VR +E + + EY +N L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
W + I+ + L+Y+H ++HRD+K NI +D N ++ DFGLAK +
Sbjct: 115 RDEYWRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 306 SERSYVT-------------TRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITG 351
+ T +GT YVA E TG NEK D+YS GI+ E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 352 RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
+S VN++ L+++ E D KM K + R+L +D D
Sbjct: 228 -----FSTGMERVNILKKLRSV----SIEFPPDFDDNKMKVEKKIIRLL------IDHDP 272
Query: 412 TKRP 415
KRP
Sbjct: 273 NKRP 276
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG--TFGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L + + F +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 59 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ +++YE++ G L + + + + ++ D + + KGL ++HE VH
Sbjct: 119 DDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 172
Query: 278 RDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
D+K NI+ R ++ DFGL L ++S T GT + APE A +
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 230
Query: 336 SDVYSFGILIMEIITGRNPV 355
+D++S G+L +++G +P
Sbjct: 231 TDMWSVGVLSYILLSGLSPF 250
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG--TFGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L + + F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGT-FGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L ++ YV F +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGT-FGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L ++ YV F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGT-FGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L ++ YV F +
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+L + + Y LV E G L ++ + II G+ Y H+
Sbjct: 89 XKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
K+VHRD+K N+LL+ + N R+ DFGL+ E S +GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAPE- 198
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
G +EK DV+S G+++ +++G P +
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGT-FGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L ++ YV F +
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 215 YCVEG------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
+E Y + + NL W++G + + ++I L A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAE 129
Query: 263 GLAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVT------ 312
+ +LH +GL +HRD+K SNI +V DFGL + E++ +T
Sbjct: 130 AVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 313 --TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349
T +GT Y++PE + K D++S G+++ E++
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ +++YE++ G L + + + +S D + + KGL ++HE VH
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSE---DEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 278 RDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
D+K NI+ R ++ DFGL L ++S T GT + APE A +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 336
Query: 336 SDVYSFGILIMEIITGRNPV 355
+D++S G+L +++G +P
Sbjct: 337 TDMWSVGVLSYILLSGLSPF 356
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 159 IGEGGYGIVYRGILS----DGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG VAVK L + ++ +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGT-FGY 321
+ YL + +HRD+ + N+LL + ++ DFGL + L ++ YV F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE T + SD + FG+ + E+ T G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DF LA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + +L G VAVK L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q +H ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ C+ +++ T + T Y APE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPE 195
Query: 326 YACTGMLNEKSDVYSFGILIMEIITG 351
D++S G ++ E++ G
Sbjct: 196 VILGMGYAANVDIWSVGCIMGELVKG 221
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V T+VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 51 IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDI 109
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKS-QQLSNDHICYFLYQILRGLKYIHSA---NV 165
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+L++ + ++ DFGLA++ E + T + T Y APE MLN
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI----MLN 221
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ FGLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + K E++ + RH +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+L +V EYV G L ++ HG V ++ + + Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQILSAVDYCH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ VVHRD+K N+LLD NA+++DFGL+ ++ S+ ++ G+ Y APE
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC-GSPNYAAPE-VI 182
Query: 329 TGML--NEKSDVYSFGILIMEIITGRNPVD 356
+G L + D++S G+++ ++ G P D
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 65.5 bits (158), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 35/284 (12%)
Query: 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +V + KVA+K + + Q E E++ + + H N+V
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 214 GYCVEGAYRMLVYEYVDNGN-LDQWLH--------GDVGDVSPLTWDIRMNIILGTAKGL 264
V LV + + G+ LD H V D S + I+ +GL
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGL 134
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----ERSYVTTRVMGTFG 320
YLH+ + +HRDVK+ NILL + +++DFG++ L + R+ V +GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 321 YVAPE-YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
++APE + K+D++SFGI +E+ TG P P + L T+ S
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQNDPPS 246
Query: 380 EE--VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
E V D ++ K K + L C+ D KRP ++
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELL 286
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 65.5 bits (158), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 35/284 (12%)
Query: 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +V + KVA+K + + Q E E++ + + H N+V
Sbjct: 15 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 214 GYCVEGAYRMLVYEYVDNGN-LDQWLH--------GDVGDVSPLTWDIRMNIILGTAKGL 264
V LV + + G+ LD H V D S + I+ +GL
Sbjct: 75 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGL 129
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----ERSYVTTRVMGTFG 320
YLH+ + +HRDVK+ NILL + +++DFG++ L + R+ V +GT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 321 YVAPEYA-CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
++APE + K+D++SFGI +E+ TG P P + L T+ S
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQNDPPS 241
Query: 380 EE--VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
E V D ++ K K + L C+ D KRP ++
Sbjct: 242 LETGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELL 281
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.5 bits (158), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ D GLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLE 272
+ Y++ + ++ D+ + L + ++ KGL Y+H
Sbjct: 91 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA-- 145
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGM 331
VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR Y APE + M
Sbjct: 146 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 199
Query: 332 -LNEKSDVYSFGILIMEIITGRN 353
N+ D++S G ++ E++TG+
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKT 222
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 87/326 (26%), Positives = 142/326 (43%), Gaps = 25/326 (7%)
Query: 87 PEIQVDIGKIEHRVVFSDRASSGESRGTGSA-CETASFGSGSVGPEVSHLGWGRWYTLRE 145
P+ Q+ ++ V RA +G+ A G + L + R+ +
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKW 176
Query: 146 LEAATSG---LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFK---VEV 198
LEA G + V+G GG+G V+ + + G A K L R + K ++ VE
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
+++ +V H + L Y E + + + NG ++ +V + +P + R I
Sbjct: 237 KILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IF 293
Query: 259 GTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
TA+ GL +LH+ +++RD+K N+LLD N R+SD GLA L + ++ T
Sbjct: 294 YTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGY 349
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375
GT G++APE + D ++ G+ + E+I R P R +GE LK
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKVENKELK---- 402
Query: 376 SRKSEEVVDPKLPKMPASKALKRVLL 401
R E+ V PASK LL
Sbjct: 403 QRVLEQAVTYPDKFSPASKDFCEALL 428
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 159 IGEGGYGIVYRGI--LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y VY+G L+D VA+K + L + A EV ++ ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q+L D G++ + ++++ + +GLAY H KV
Sbjct: 69 IHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMH-NVKL-FLFQLLRGLAYCHRQ---KV 121
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM-LNE 334
+HRD+K N+L++ + +++DFGLA+ V+ T Y P+ +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 335 KSDVYSFGILIMEIITGR 352
+ D++ G + E+ TGR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
++ SD+++ G +I +++ G P
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 87/326 (26%), Positives = 142/326 (43%), Gaps = 25/326 (7%)
Query: 87 PEIQVDIGKIEHRVVFSDRASSGESRGTGSA-CETASFGSGSVGPEVSHLGWGRWYTLRE 145
P+ Q+ ++ V RA +G+ A G + L + R+ +
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKW 176
Query: 146 LEAATSG---LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFK---VEV 198
LEA G + V+G GG+G V+ + + G A K L R + K ++ VE
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
+++ +V H + L Y E + + + NG ++ +V + +P + R I
Sbjct: 237 KILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IF 293
Query: 259 GTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
TA+ GL +LH+ +++RD+K N+LLD N R+SD GLA L + ++ T
Sbjct: 294 YTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGY 349
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375
GT G++APE + D ++ G+ + E+I R P R +GE LK
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKVENKELK---- 402
Query: 376 SRKSEEVVDPKLPKMPASKALKRVLL 401
R E+ V PASK LL
Sbjct: 403 QRVLEQAVTYPDKFSPASKDFCEALL 428
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 16 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 74 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 130 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPF 212
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + +L G VAVK L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 30 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 86
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q +H ++ RM+ +L G+
Sbjct: 87 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIK 138
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ + +++ T + T Y APE
Sbjct: 139 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPE 193
Query: 326 YACTGMLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E++ G
Sbjct: 194 VILGMGYKENVDIWSVGCIMGELVKG 219
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 15 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 73 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 129 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPF 211
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + + E++ + RH +++
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L + +V EYV G L ++ + L + G+ Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH 135
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VVHRD+K N+LLD NA+++DFGL+ ++ S+ ++ G+ Y APE +G
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC-GSPNYAAPE-VISG 189
Query: 331 ML--NEKSDVYSFGILIMEIITGRNPVD 356
L + D++S G+++ ++ G P D
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFD 217
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 87/326 (26%), Positives = 142/326 (43%), Gaps = 25/326 (7%)
Query: 87 PEIQVDIGKIEHRVVFSDRASSGESRGTGSA-CETASFGSGSVGPEVSHLGWGRWYTLRE 145
P+ Q+ ++ V RA +G+ A G + L + R+ +
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKW 176
Query: 146 LEAATSG---LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFK---VEV 198
LEA G + V+G GG+G V+ + + G A K L R + K ++ VE
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
+++ +V H + L Y E + + + NG ++ +V + +P + R I
Sbjct: 237 KILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IF 293
Query: 259 GTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
TA+ GL +LH+ +++RD+K N+LLD N R+SD GLA L + ++ T
Sbjct: 294 YTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGY 349
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375
GT G++APE + D ++ G+ + E+I R P R +GE LK
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKVENKELK---- 402
Query: 376 SRKSEEVVDPKLPKMPASKALKRVLL 401
R E+ V PASK LL
Sbjct: 403 QRVLEQAVTYPDKFSPASKDFCEALL 428
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E V TR Y APE
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYRAPEIMLNW 217
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRT 241
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ D GLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHRD+K NILL+ + + ++ DFGL+ C +++ +GT Y+APE G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPE-VLRGT 198
Query: 332 LNEKSDVYSFGILIMEIITGRNPV 355
+EK DV+S G+++ +++G P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPF 222
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG GG+ V + G VA+K + N G K E+E + +RH+++ +L
Sbjct: 18 IGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVL 77
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+V EY G L ++ L+ + + +AY+H
Sbjct: 78 ETANKIFMVLEYCPGGELFDYIISQ----DRLSEEETRVVFRQIVSAVAYVHSQ---GYA 130
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TGMLNEK 335
HRD+K N+L D ++ DFGL + Y G+ Y APE L +
Sbjct: 131 HRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSE 190
Query: 336 SDVYSFGILIMEIITGRNPVD 356
+DV+S GIL+ ++ G P D
Sbjct: 191 ADVWSMGILLYVLMCGFLPFD 211
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 128 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPF 210
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 13 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 71 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 126
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 127 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPF 209
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 30/266 (11%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLG 214
+G G YG+V R + S G +AVK + Q +K +++++ R V V G
Sbjct: 15 LGRGAYGVVEKMRHVPS-GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ E +D +LD++ + + DI I + K L +LH L
Sbjct: 74 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
V+HRDVK SN+L++ ++ DFG++ L + + G Y+APE LN+
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPE-RINPELNQ 187
Query: 335 -----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
KSD++S GI ++E+ R P D W ++ ++VV+ P+
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPF---QQLKQVVEEPSPQ 233
Query: 390 MPASKALKRVLLVALRCVDPDATKRP 415
+PA K + +C+ ++ +RP
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSKERP 259
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 39 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 97 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPF 235
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 39 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 97 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPF 235
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E +GT YV+PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E +GT YV+PE
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 28 LCE--VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 207 KNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDV-SPLTWDIRMNIILGTAK 262
++V LL Y +G M V+E++D +L + D G V S M IL +
Sbjct: 86 PHIVELLETYSSDGMLYM-VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---E 141
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 319
L Y H+ ++HRDVK N+LL + N+ ++ DFG+A L E V +GT
Sbjct: 142 ALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTP 197
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
++APE + DV+ G+++ +++G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ D GLA+ E + YV TR Y APE
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 331 M-LNEKSDVYSFGILIMEIITGRN 353
M N+ D++S G ++ E++TGR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLE 272
+ Y++ + ++ D+ + + + ++ KGL Y+H
Sbjct: 109 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA-- 163
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGM 331
VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR Y APE + M
Sbjct: 164 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 217
Query: 332 -LNEKSDVYSFGILIMEIITGRN 353
N+ D++S G ++ E++TG+
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKT 240
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 88 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHL 142
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGYVAPE 325
H +++RD+K NILLD + + +++DFGL+K + +++Y GT Y+APE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPE 196
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPV 355
+ +D +SFG+L+ E++TG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHRD+K NILL+ + + ++ DFGL+ C +++ +GT Y+APE G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPE-VLRGT 198
Query: 332 LNEKSDVYSFGILIMEIITGRNPV 355
+EK DV+S G+++ +++G P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPF 222
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 41 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L + Y NG L +++ +G I+ L YLH
Sbjct: 99 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 154
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACT 329
++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 155 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPF 237
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHRD+K NILL+ + + ++ DFGL+ C +++ +GT Y+APE G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPE-VLRGT 198
Query: 332 LNEKSDVYSFGILIMEIITGRNPV 355
+EK DV+S G+++ +++G P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPF 222
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 511 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 157 NVIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ R + + KV K L R + K+E +++ V H
Sbjct: 34 KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT--KMERDILADVNHPF 91
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A GL +L
Sbjct: 92 VVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALGLDHL 146
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H +++RD+K NILLD + + +++DFGL+K + GT Y+APE
Sbjct: 147 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEVV 202
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPV 355
+ +D +S+G+L+ E++TG P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPF 230
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEFKV----EVEVIGRVR---HKNL 209
IG G YG VY+ G VA+K++ + N G + EV ++ R+ H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 210 VRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
VRL+ C LV+E+VD +L +L D L + +++ +GL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGL 133
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
+LH +VHRD+K NIL+ +++DFGLA++ + + T V+ T Y AP
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVTLWYRAP 188
Query: 325 EYACTGMLNEKSDVYSFGILIMEII 349
E D++S G + E+
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMF 213
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 24/273 (8%)
Query: 139 RWYTLRELEAATSG---LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEF 194
R+ + LEA G + V+G GG+G V+ + + G A K L R + K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 195 K---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ VE +++ +V H + L Y E + + + NG ++ +V + +P +
Sbjct: 230 QGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 252 IRMNIILGTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
R I TA+ GL +LH+ +++RD+K N+LLD N R+SD GLA L + +
Sbjct: 289 PRA--IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368
+ T GT G++APE + D ++ G+ + E+I R P R +GE
Sbjct: 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKVENK 399
Query: 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
LK R E+ V PASK LL
Sbjct: 400 ELK----QRVLEQAVTYPDKFSPASKDFCEALL 428
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 20 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 78 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 134 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPF 216
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H +VHRD+K NIL+ +++DFGLA++ + + V+ T Y APE
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP--VVVTLWYRAPEVL 183
Query: 328 CTGMLNEKSDVYSFGILIMEII 349
D++S G + E+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMF 205
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 60 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 114
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 173
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 174 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 225
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 282
Query: 382 V 382
+
Sbjct: 283 I 283
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H +VHRD+K NIL+ +++DFGLA++ + + V+ T Y APE
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP--VVVTLWYRAPEVL 183
Query: 328 CTGMLNEKSDVYSFGILIMEII 349
D++S G + E+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMF 205
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 158 VIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V +L+D K+ K+++ E VE V+ +
Sbjct: 26 VLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTM-VEKRVLALLDKPPF 81
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L C + R+ V EYV+ G+L + G + + + ++I GL +
Sbjct: 82 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFF 135
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTR-VMGTFGYVA 323
LH+ +++RD+K N++LD + + +++DFG +C E VTTR GT Y+A
Sbjct: 136 LHKR---GIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMMDGVTTREFCGTPDYIA 188
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
PE + D +++G+L+ E++ G+ P D
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 62 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 116
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 175
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 176 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 227
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 284
Query: 382 V 382
+
Sbjct: 285 I 285
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 112
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 171
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 223
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 280
Query: 382 V 382
+
Sbjct: 281 I 281
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 39 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 95
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 96 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 151
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 207
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 199
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 71/255 (27%), Positives = 117/255 (45%), Gaps = 53/255 (20%)
Query: 120 TASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVA 179
+ + GSGS P + R TL E +G+G YG V+RG G VA
Sbjct: 18 SCTSGSGSGLPFLVQRTVARQITLLE------------CVGKGRYGEVWRGSWQ-GENVA 64
Query: 180 VKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYCVEGAYR----MLVYEYVDNGN 233
VK + ++R EK + E E+ V RH+N++ + + + L+ Y + G+
Sbjct: 65 VK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 121
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-----EPKVVHRDVKSSNILLD 288
L +L D + I+L A GLA+LH + +P + HRD+KS NIL+
Sbjct: 122 LYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 176
Query: 289 RQWNARVSDFGLAKLLCSERSYVTT----RVMGTFGYVAPEYACTGMLNE---------- 334
+ ++D GLA + + + RV GT Y+APE +L+E
Sbjct: 177 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE-----VLDETIQVDCFDSY 230
Query: 335 -KSDVYSFGILIMEI 348
+ D+++FG+++ E+
Sbjct: 231 KRVDIWAFGLVLWEV 245
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 103 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 157
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 216
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 217 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 268
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 325
Query: 382 V 382
+
Sbjct: 326 I 326
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G+++ E+I G
Sbjct: 201 GYKENVDIWSVGVIMGEMIKG 221
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 19 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 79 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 133 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 190 RFTSASDVWMFGVCMWEIL 208
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 165
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 221
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 205
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 199
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 89
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 90 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 201
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G+++ E+I G
Sbjct: 201 GYKENVDIWSVGVIMGEMIKG 221
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 95 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 150
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 206
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 35 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 93 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPF 231
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 95
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 96 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 151
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 207
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 86
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 87 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 142
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 198
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 205
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 20 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 80 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 134 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 191 RFTSASDVWMFGVCMWEIL 209
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 52 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 106
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 165
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 166 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 217
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 274
Query: 382 V 382
+
Sbjct: 275 I 275
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 88 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 143
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 199
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 31/252 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 80 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 131
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML- 332
K+VHRD+K N+LLD N +++DFGL+ ++ ++ +++ T G+ Y APE +G L
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPE-VISGKLY 188
Query: 333 -NEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ DV+S G+++ ++ R P D S P N+ + + T+ PK
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----------PKFLSP 237
Query: 391 PASKALKRVLLV 402
A+ +KR+L+V
Sbjct: 238 GAAGLIKRMLIV 249
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 88 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHL 142
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGYVAPE 325
H +++RD+K NILLD + + +++DFGL+K + +++Y GT Y+APE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPE 196
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPV 355
+ +D +SFG+L+ E++TG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK------------NLLNNRGQAEKEFKVEVEVIG 202
++VIG G +V R + + G + AVK L R +E + +V G
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
H +++ L+ ++ LV++ + G L +L V L+ +I+ +
Sbjct: 159 ---HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLE 211
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+++LH +VHRD+K NILLD R+SDFG + L E + GT GY+
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYL 266
Query: 323 APEYACTGM------LNEKSDVYSFGILIMEIITGRNPVDYSR 359
APE M ++ D+++ G+++ ++ G P + R
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 88 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 143
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 199
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 35 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 93 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPF 231
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 31/252 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 81 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 132
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML- 332
K+VHRD+K N+LLD N +++DFGL+ ++ ++ +++ T G+ Y APE +G L
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPE-VISGKLY 189
Query: 333 -NEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ DV+S G+++ ++ R P D S P N+ + + T+ PK
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----------PKFLSP 238
Query: 391 PASKALKRVLLV 402
A+ +KR+L+V
Sbjct: 239 GAAGLIKRMLIV 250
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 31 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 88
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 89 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGYVAPE 325
H +++RD+K NILLD + + +++DFGL+K + +++Y GT Y+APE
Sbjct: 144 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPE 197
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPV 355
+ +D +SFG+L+ E++TG P
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 82 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 185 RFTSASDVWMFGVCMWEIL 203
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 31/252 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 71 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 122
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML- 332
K+VHRD+K N+LLD N +++DFGL+ ++ ++ +++ T G+ Y APE +G L
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPE-VISGKLY 179
Query: 333 -NEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ DV+S G+++ ++ R P D S P N+ + + T+ PK
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----------PKFLSP 228
Query: 391 PASKALKRVLLV 402
A+ +KR+L+V
Sbjct: 229 GAAGLIKRMLIV 240
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 29 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 83
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 84 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 142
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 143 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 194
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 251
Query: 382 V 382
+
Sbjct: 252 I 252
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 38/222 (17%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
+G+G YGIV++ I G VAVK + + N A++ F+ E+ ++ + H+N+V LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
R LV++Y++ +L + ++ + P+ + ++ K + YLH G
Sbjct: 76 NVLRADNDRDVYLVFDYME-TDLHAVIRANI--LEPVH---KQYVVYQLIKVIKYLHSG- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--------------------V 311
++HRD+K SNILL+ + + +V+DFGL++ + R +
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGR 352
T + T Y APE K D++S G ++ EI+ G+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 199
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 45 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 105 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 158
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 159 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 216 RFTSASDVWMFGVCMWEIL 234
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 199
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 41/216 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYC 216
+G+G YG V+RG G VAVK + ++R EK + E E+ V RH+N++ +
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIASD 71
Query: 217 VEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL- 271
+ + L+ Y + G+L +L D + I+L A GLA+LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIF 126
Query: 272 ----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT----RVMGTFGYVA 323
+P + HRD+KS NIL+ + ++D GLA + + + RV GT Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 185
Query: 324 PEYACTGMLNE-----------KSDVYSFGILIMEI 348
PE +L+E + D+++FG+++ E+
Sbjct: 186 PE-----VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 31/252 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 75 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 126
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML- 332
K+VHRD+K N+LLD N +++DFGL+ ++ ++ +++ T G+ Y APE +G L
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPE-VISGKLY 183
Query: 333 -NEKSDVYSFGILIMEIITGRNPV-DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ DV+S G+++ ++ R P D S P N+ + + T+ PK
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----------PKFLSP 232
Query: 391 PASKALKRVLLV 402
A+ +KR+L+V
Sbjct: 233 GAAGLIKRMLIV 244
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 41/216 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYC 216
+G+G YG V+RG G VAVK + ++R EK + E E+ V RH+N++ +
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIASD 71
Query: 217 VEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL- 271
+ + L+ Y + G+L +L D + I+L A GLA+LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIF 126
Query: 272 ----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT----RVMGTFGYVA 323
+P + HRD+KS NIL+ + ++D GLA + + + RV GT Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 185
Query: 324 PEYACTGMLNE-----------KSDVYSFGILIMEI 348
PE +L+E + D+++FG+++ E+
Sbjct: 186 PE-----VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 199
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 157 NVIGEGGYGI-VYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
G ++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPV 355
+ SD+++ G +I +++ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+V + + +VA+K + Q + + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ Y+ ++ L+ + L+ D + +GL Y+H V+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLNE 334
HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNS 206
Query: 335 KS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 37 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 91
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 92 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 150
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 151 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 202
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 259
Query: 382 V 382
+
Sbjct: 260 I 260
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 205
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
IG G Y + R I + + AVK + +++++ E+E++ R +H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+G Y +V E + G L D+ L + ++ K + YLH V
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEYLHAQ---GV 137
Query: 276 VHRDVKSSNIL-LDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
VHRD+K SNIL +D N R+ DFG AK L +E + T T +VAPE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQG 196
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+ D++S G+L+ ++TG P
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTP 219
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H +VHRD+K NIL+ +++DFGLA++ + + V+ T Y APE
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--DPVVVTLWYRAPEVL 183
Query: 328 CTGMLNEKSDVYSFGILIMEII 349
D++S G + E+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMF 205
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 41/243 (16%)
Query: 125 SGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL 183
SG EV+ W R+L+ +G G YG V + G KVA+K L
Sbjct: 9 SGFYRQEVTKTAWEVRAVYRDLQP----------VGSGAYGAVCSAVDGRTGAKVAIKKL 58
Query: 184 ---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--------YRMLVYEYVDNG 232
+ A++ ++ E+ ++ +RH+N++ LL Y ++ + D G
Sbjct: 59 YRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
L + H +G+ D ++ KGL Y+H ++HRD+K N+ ++
Sbjct: 118 KLMK--HEKLGE------DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCE 166
Query: 293 ARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIIT 350
++ DFGLA+ SE V TR Y APE M + D++S G ++ E+IT
Sbjct: 167 LKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 351 GRN 353
G+
Sbjct: 222 GKT 224
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++
Sbjct: 51 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG-- 105
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHG----DVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ R E + + L L G + L+ D + +GL Y+H
Sbjct: 106 ---INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYA 327
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE
Sbjct: 163 A---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI- 218
Query: 328 CTGMLNEKS-----DVYSFGILIMEIITGR 352
MLN K D++S G ++ E+++ R
Sbjct: 219 ---MLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYV 322
+H + HRD+K N+LLD ++ DFG AK L SY+ +R Y
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 189
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
APE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQ 246
Query: 382 V 382
+
Sbjct: 247 I 247
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 33/269 (12%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+V+HRD+K N+ L+ + ++ DFGLA + + T + GT Y+APE C +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHS 220
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKSEEVVDPKLPKMPA 392
+ D++S G ++ ++ G+ P + S LK T + +K+E V + P
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFETS----------CLKETYIRIKKNEYSVPRHI--NPV 268
Query: 393 SKALKRVLLVALRCVDPDATKRPKMGHVI 421
+ AL R +L A D T RP + ++
Sbjct: 269 ASALIRRMLHA------DPTLRPSVAELL 291
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 157 NVIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G G YG V+ R I T KV K + + + + + E +V+ +R
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 209 LVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG-TAKGLAY 266
+ L Y + ++ L+ +Y++ G L + H + T + + I +G L +
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTH--LSQRERFT-EHEVQIYVGEIVLALEH 174
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
LH+ +++RD+K NILLD + ++DFGL+K ++ + GT Y+AP+
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 327 ACTGML--NEKSDVYSFGILIMEIITGRNP 354
G ++ D +S G+L+ E++TG +P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 37/261 (14%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRLLGYC 216
VIG G +G+V++ L + +VA+K +L +K FK E++++ V+H N+V L +
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 217 VEG------AYRMLVYEYVDNGNLDQWLH-GDVGDVSP-LTWDIRMNIILGTAKGLAYLH 268
+ LV EYV H + P L + M +L + LAY+H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIH 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
+ HRD+K N+LLD ++ DFG AK+L + V+ + + Y APE
Sbjct: 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYRAPEL- 212
Query: 328 CTGMLNEKS--DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM-VGSRKSEEVVD 384
G N + D++S G ++ E++ G+ P+ + G LV+ +K + SR+ + ++
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PL-FPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 385 P-----KLPKM---PASKALK 397
P K P++ P SK +
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFR 291
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 28/240 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + +E ++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLR 79
Query: 214 GYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYVA 323
H + HRD+K N+LLD ++ DFG AK L SY+ +R Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 190
Query: 324 PEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
PE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 28/240 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + +E ++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLR 79
Query: 214 GYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTRVMGTFGYVA 323
H + HRD+K N+LLD ++ DFG AK L SY+ +R Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 190
Query: 324 PEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
PE S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
++G G +G V++ + G K+A K ++ RG +KE K E+ V+ ++ H NL++L
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+LV EYVD G L + + +++ L + M I +G+ ++H+ +
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI---CEGIRHMHQMY---I 208
Query: 276 VHRDVKSSNIL-LDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+H D+K NIL ++R ++ DFGLA+ GT ++APE ++
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVS 266
Query: 334 EKSDVYSFGILIMEIITGRNP 354
+D++S G++ +++G +P
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP 287
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA++ + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE MLN
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLN 205
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEFK---VEVEVIGRV-RHKNLVRL 212
++G+G +G V+ + A+K L + + + + VE V+ H L +
Sbjct: 25 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
V EY++ G+L + D+S T+ IILG L +LH
Sbjct: 85 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILG----LQFLHSK- 138
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGYVAPEYACT 329
+V+RD+K NILLD+ + +++DFG+ K +L + T GT Y+APE
Sbjct: 139 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTPDYIAPEILLG 193
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPV 355
N D +SFG+L+ E++ G++P
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPF 219
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
V+G G + V+ + L+ G A+K + + + + E+ V+ +++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 216 CVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ LV + V G L D+ L V + I+ +L K YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--VLSAVK---YLHEN---G 126
Query: 275 VVHRDVKSSNIL-LDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHRD+K N+L L + N+++ +DFGL+K+ E++ + + GT GYVAPE
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
++ D +S G++ ++ G P
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPP 206
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH+
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K N+L LD +SDFGL+K+ + V + GT GYVAPE
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLA 191
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D +S G++ ++ G P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 16/199 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + ++ ++APE
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 331 MLNEKSDVYSFGILIMEII 349
SDV+ FG+ + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 305
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE
Sbjct: 306 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 359
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPV 355
G+ + S D +S G ++ +++ G +P
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEFK---VEVEVIGRV-RHKNLVRL 212
++G+G +G V+ + A+K L + + + + VE V+ H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
V EY++ G+L + D+S T+ IILG L +LH
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILG----LQFLHSK- 137
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGYVAPEYACT 329
+V+RD+K NILLD+ + +++DFG+ K +L + T GT Y+APE
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPDYIAPEILLG 192
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPV 355
N D +SFG+L+ E++ G++P
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPF 218
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 360
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPV 355
G+ + S D +S G ++ +++ G +P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH+
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K N+L LD +SDFGL+K+ + V + GT GYVAPE
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLA 191
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D +S G++ ++ G P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + +V V +N +K K E+ ++ ++ H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD-AF 117
Query: 218 EGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E Y M L+ E++ G L + + +S +N + +GL ++HE +V
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEH---SIV 171
Query: 277 HRDVKSSNILLD--RQWNARVSDFGLA-KLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
H D+K NI+ + + + ++ DFGLA KL E VTT T + APE +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 228
Query: 334 EKSDVYSFGILIMEIITGRNPV 355
+D+++ G+L +++G +P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPF 250
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV- 217
+G+G YG V+RG L G VAVK + ++R + + E+ +RH N++ + +
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 218 ---EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--- 271
L+ Y ++G+L +L L + + + + A GLA+LH +
Sbjct: 74 SRNSSTQLWLITHYHEHGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 272 --EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV----TTRVMGTFGYVAPE 325
+P + HRD KS N+L+ ++D GLA + Y+ RV GT Y+APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPE 187
Query: 326 YACTGMLNEK-----------SDVYSFGILIMEI 348
+L+E+ +D+++FG+++ EI
Sbjct: 188 -----VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 76/304 (25%), Positives = 121/304 (39%), Gaps = 70/304 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVX 54
Query: 200 VIGRVRHKNLVRLLGYCVE-------------GAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H+ +VR +E + + EY +N L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
W + I+ + L+Y+H ++HR++K NI +D N ++ DFGLAK +
Sbjct: 115 RDEYWRLFRQIL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVH 167
Query: 306 SERSYVT-------------TRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITG 351
+ T +GT YVA E TG NEK D YS GI+ E I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI-- 225
Query: 352 RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
+S VN++ L+++ E D K K + R+L +D D
Sbjct: 226 ---YPFSTGXERVNILKKLRSV----SIEFPPDFDDNKXKVEKKIIRLL------IDHDP 272
Query: 412 TKRP 415
KRP
Sbjct: 273 NKRP 276
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 37/271 (13%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ + ++ DFGLA + ER + GT Y+APE C
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KXLCGTPNYIAPEVLCKKG 218
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKSEEVVDPKLPKM 390
+ + D++S G ++ ++ G+ P + S LK T + +K+E V +
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS----------CLKETYIRIKKNEYSVPRHI--N 266
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVI 421
P + AL R +L A D T RP + ++
Sbjct: 267 PVASALIRRMLHA------DPTLRPSVAELL 291
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 360
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPV 355
G+ + S D +S G ++ +++ G +P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 360
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPV 355
G+ + S D +S G ++ +++ G +P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 63
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 64 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 118
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 178
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 179 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 101
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 102 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 37/271 (13%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ + ++ DFGLA + ER + GT Y+APE C
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKG 218
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKSEEVVDPKLPKM 390
+ + D++S G ++ ++ G+ P + S LK T + +K+E V +
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS----------CLKETYIRIKKNEYSVPRHI--N 266
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVI 421
P + AL R +L A D T RP + ++
Sbjct: 267 PVASALIRRMLHA------DPTLRPSVAELL 291
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 80 EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCHQKF 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
+VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKK 188
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
IG G Y + R I + + AVK + +++++ E+E++ R +H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNXEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+G Y +V E G L D+ L + ++ K + YLH V
Sbjct: 86 DDGKYVYVVTELXKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEYLHAQ---GV 137
Query: 276 VHRDVKSSNIL-LDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
VHRD+K SNIL +D N R+ DFG AK L +E + T T +VAPE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQG 196
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+ D++S G+L+ +TG P
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYTP 219
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 62
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 63 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 178 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 37 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 88
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 89 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 143
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 203
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 204 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 80 EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCHQKF 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
+VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKK 188
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH+
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K N+L LD +SDFGL+K+ + V + GT GYVAPE
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLA 191
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D +S G++ ++ G P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH+
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K N+L LD +SDFGL+K+ + V + GT GYVAPE
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLA 191
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D +S G++ ++ G P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 68
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 69 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 123
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 183
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 184 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY 215
V+ EGG+ VY + G + A+K LL+N + + EV + ++ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 216 CV-------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G L+ + G L ++L + PL+ D + I T + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVM--G 317
+P ++HRD+K N+LL Q ++ DFG A + R+ V +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 318 TFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNPVD 356
T Y PE + EK D+++ G ++ + ++P +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 65
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 66 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 120
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT---TRVMGTFG 320
+ +P + HRD+KS NIL+ + ++D GLA S + +GT
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 180
Query: 321 YVAPEYACTGMLNEK-------SDVYSFGILIMEI 348
Y+APE +N K +D+Y+ G++ EI
Sbjct: 181 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 28/265 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
+G G YG+V + + G AVK + Q +K ++++ R V V G
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ E D +LD++ + + DI I + K L +LH L V
Sbjct: 102 LFREGDVWICXELXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 158
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE- 334
+HRDVK SN+L++ + DFG++ L + + G Y APE LN+
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--AGCKPYXAPE-RINPELNQK 215
Query: 335 ----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
KSD++S GI +E+ R P D W ++ ++VV+ P++
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYD-----------SWGTPF---QQLKQVVEEPSPQL 261
Query: 391 PASKALKRVLLVALRCVDPDATKRP 415
PA K + +C+ ++ +RP
Sbjct: 262 PADKFSAEFVDFTSQCLKKNSKERP 286
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + + T Y APE MLN
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLN 205
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 37/271 (13%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 34 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 93 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ + ++ DFGLA + ER + GT Y+APE C
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKG 202
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKSEEVVDPKLPKM 390
+ + D++S G ++ ++ G+ P + S LK T + +K+E V +
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETS----------CLKETYIRIKKNEYSVPRHI--N 250
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVI 421
P + AL R +L A D T RP + ++
Sbjct: 251 PVASALIRRMLHA------DPTLRPSVAELL 275
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 95 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 150
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLN 333
+HRD+K SN+LL+ + ++ DFGLA++ + + + T Y APE MLN
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLN 206
Query: 334 EKS-----DVYSFGILIMEIITGR 352
K D++S G ++ E+++ R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 195
Query: 326 YACTGMLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 112
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 171
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L R + + Y APE
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRYYRAPE 226
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 281
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 202 GYKENVDIWSVGCIMGEMIKG 222
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 28/259 (10%)
Query: 107 SSGESRGTGSA-CETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYG 165
SSG GT + ++ S + S P + L W +A + E+ +G G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 166 IVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225
IVYR GT+ + + +K + E+ V+ R+ H N+++L LV
Sbjct: 68 IVYR-CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 226 YEYVDNGNL-------DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
E V G L + D D + + +AYLHE +VHR
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADA-----------VKQILEAVAYLHEN---GIVHR 172
Query: 279 DVKSSNILLDR---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
D+K N+L +++DFGL+K++ E + V GT GY APE +
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 336 SDVYSFGILIMEIITGRNP 354
D++S GI+ ++ G P
Sbjct: 231 VDMWSVGIITYILLCGFEP 249
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G V+ S G + +K + +R Q E + E+EV+ + H N++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E + G L + + L+ ++ LAY H VV
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 277 HRDVKSSNILLDR---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
H+D+K NIL ++ DFGLA+L S+ +T GT Y+APE +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE-VFKRDVT 203
Query: 334 EKSDVYSFGILIMEIITGRNP 354
K D++S G+++ ++TG P
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLP 224
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 47 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 103
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 158
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACT 329
+V+HRD+K N+ L+ ++ DFGLA + ER V + GT Y+APE
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 213
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 242
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + IV R GT K K L++ RG + +E + EV ++ +RH N++
Sbjct: 13 LGSGQFAIV-RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT D + G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 271 LEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
++ H D+K NI LLD+ N R+ DFG+A + + + + GT +VAPE
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASP 210
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + IV R GT K K L++ RG + +E + EV ++ +RH N++
Sbjct: 20 LGSGQFAIV-RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT D + G+ YLH
Sbjct: 79 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHS- 133
Query: 271 LEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
++ H D+K NI LLD+ N R+ DFG+A + + + + GT +VAPE
Sbjct: 134 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 189
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 49 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 105
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 160
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACT 329
+V+HRD+K N+ L+ ++ DFGLA + ER V + GT Y+APE
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 215
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 244
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGIN 89
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 90 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 201
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 36 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 90
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L R + + Y APE
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRYYRAPE 204
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 259
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 36 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 90
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 204
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 259
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + +E + EV ++ +RH N++ L +L+ E V G L +L +
Sbjct: 69 RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKE 124
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAK 302
LT D + G+ YLH ++ H D+K NI LLD+ N R+ DFG+A
Sbjct: 125 SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 182 KIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 43 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 97
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 98 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 156
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L R + + Y APE
Sbjct: 157 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRYYRAPE 211
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 266
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
+ G + IG G Y R + + + AVK + +++++ E+E++ R +H
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L +G + LV E + G L D+ L ++ ++ K + Y
Sbjct: 82 NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEY 136
Query: 267 LHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
LH VVHRD+K SNIL +D N R+ DFG AK L +E + T T +V
Sbjct: 137 LHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFV 192
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE +E D++S GIL+ ++ G P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG +G V KVA+K + L + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++V EY G L + + + +T D + Y H K
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDY----IVEKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-- 332
+VHRD+K N+LLD N +++DFGL+ ++ ++ +++ T G+ Y APE G L
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPE-VINGKLYA 185
Query: 333 NEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S GI++ ++ GR P D
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD 209
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 32 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 86
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 87 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 145
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L R + + Y APE
Sbjct: 146 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRYYRAPE 200
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 255
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 29 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 86 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ ++ DFGLA + + T + GT Y+APE
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 197
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETS 224
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 192
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAV+ + N +K F+ EV ++ + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 80 EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCHQKF 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
+VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKK 188
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 195
Query: 326 YACTGMLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 192
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 28 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 82
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 83 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 141
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 142 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 196
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 251
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 25 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 79
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 80 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 138
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 139 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 193
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 248
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 80 EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCHQKF 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHRD+K+ N+LLD N +++DFG + + + F AP YA +
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSN------EFTFGNKLDAFC-GAPPYAAPEL 183
Query: 332 LNEKS------DVYSFGILIMEIITGRNPVD 356
K DV+S G+++ +++G P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 188
Query: 326 YACTGMLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGIN 89
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 90 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVAPEYACTGM 331
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE M
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----M 201
Query: 332 LNEKS-----DVYSFGILIMEIITGR 352
LN K D++S G ++ E+++ R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 25 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ ++ DFGLA + + T + GT Y+APE
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
+ G + IG G Y R + + + AVK + +++++ E+E++ R +H
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L +G + LV E + G L D+ L ++ ++ K + Y
Sbjct: 82 NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEY 136
Query: 267 LHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
LH VVHRD+K SNIL +D N R+ DFG AK L +E + T T +V
Sbjct: 137 LHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFV 192
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE +E D++S GIL+ ++ G P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 25 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYAC 328
+V+HRD+K N+ L+ ++ DFGLA ++ Y R + GT Y+APE
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPE 192
Query: 326 YACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLCGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH ++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 195
Query: 326 YACTGMLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 23 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGYVAPEYACT 329
+V+HRD+K N+ L+ ++ DFGLA + ER V + GT Y+APE
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 189
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYS 358
+ + DV+S G ++ ++ G+ P + S
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 34 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 91 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 147
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ + T Y APE
Sbjct: 148 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 331 MLNEKSDVYSFGILIMEIITG 351
E D++S G ++ E+I G
Sbjct: 203 GYKENVDIWSVGCIMGEMIKG 223
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 158 VIGEGGYG-IVYRGILSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G ++ ++ AVK L + + EK E V+ + V+H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + A ++ V +Y++ G L L + + P I A L YLH
Sbjct: 105 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHSL- 158
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+RD+K NILLD Q + ++DFGL K S T+ GT Y+APE
Sbjct: 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHKQP 215
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364
+ D + G ++ E++ G P YSR E+
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM 247
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 15 IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 73 EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARA---KFRQIVSAVQ---YCHQKF 126
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
+VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKK 181
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD 207
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VA+K + N +K F+ EV ++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L+ EY G + +L HG + + + + I+ + Y H+
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCHQ-- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++VHRD+K+ N+LLD N +++DFG S V ++ G AP YA +
Sbjct: 133 -KRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGKLDAFCG--APPYAAPEL 184
Query: 332 LNEKS------DVYSFGILIMEIITGRNPVD 356
K DV+S G+++ +++G P D
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 24/181 (13%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P+ I + + K L YL E + V+HRDVK SNILLD + ++ DFG++ L
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 307 ERSYVTTRVMGTFGYVAPEY-----ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361
+++ R G Y+APE + ++DV+S GI ++E+ TG+ P +
Sbjct: 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR-CVDPDATKRPKMGHV 420
EV +V+ + P +P ++ C+ D KRPK +
Sbjct: 236 FEV--------------LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
Query: 421 I 421
+
Sbjct: 282 L 282
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 127 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 184 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 148
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHR++K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 206
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
++ D+++ G+++ ++ G P
Sbjct: 207 YSKPVDIWACGVILYILLVGYPP 229
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAV+ + N +K F+ EV ++ + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 80 EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCHQKF 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
+VHRD+K+ N+LLD N +++DFG + G+ Y APE +
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGKK 188
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VA+K + N +K F+ EV ++ + H N+V+L
Sbjct: 20 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 77
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L+ EY G + +L HG + + + + I+ + Y H+
Sbjct: 78 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCHQ-- 129
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTG 330
++VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 130 -KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQGKK 186
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFD 212
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 31 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 88 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 144
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 145 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 200 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 231
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 127 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 184 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 22/237 (9%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + + E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLR 79
Query: 214 GYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
H + HRD+K N+LLD ++ DFG AK L V+ + + Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPEL 193
Query: 327 ACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
S DV+S G ++ E++ G+ P+ + G LV+ +K + G+ E++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPGDSGVDQLVEIIKVL-GTPTREQI 247
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHR++K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
++ D+++ G+++ ++ G P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 82 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 13 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 72 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 124
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHR++K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 182
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
++ D+++ G+++ ++ G P
Sbjct: 183 YSKPVDIWACGVILYILLVGYPP 205
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVT------TRVMG 317
LH V+HRD+K SN+L++ + +V DFGLA+++ ++ S T T +
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 318 TFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGR 352
T Y APE T ++ DV+S G ++ E+ R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+VHR++K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
++ D+++ G+++ ++ G P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVT------TRVMG 317
LH V+HRD+K SN+L++ + +V DFGLA+++ ++ S T T +
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 318 TFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGR 352
T Y APE T ++ DV+S G ++ E+ R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTK-VAVKNL-LNNRGQAE----KEFKVEVEVIGRVRHKNLV 210
+ +GEG + VY+ + + VA+K + L +R +A+ + E++++ + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL + LV+++++ +L+ + + ++P M L T +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLHQH 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACT 329
++HRD+K +N+LLD +++DFGLAK S R+Y V T Y APE
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFG 186
Query: 330 G-MLNEKSDVYSFGILIMEII 349
M D+++ G ++ E++
Sbjct: 187 ARMYGVGVDMWAVGCILAELL 207
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 156 ENVIGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLV 210
+ IG+G + V R +L+ G +VAVK + N +K F+ EV ++ + H N+V
Sbjct: 20 QKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+L LV EY G + +L HG + + + I+ + Y H
Sbjct: 78 KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA---KFRQIVSAVQ---YCH 131
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YA 327
+ +VHRD+K+ N+LLD N +++DFG + T G+ Y APE +
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQ 186
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVD 356
+ DV+S G+++ +++G P D
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+ E G +++G G + VK L + + ++F E + H N++ +LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 217 --VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ L+ ++ G+L LH V + ++ L A+G+A+LH LEP
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK--FALDMARGMAFLH-TLEPL 133
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM--L 332
+ + S ++++D AR+S + + S+ + M +VAPE
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 333 NEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK-- 389
N +S D++SF +L+ E++T EV D +G + + E + P +P
Sbjct: 188 NRRSADMWSFAVLLWELVTR-----------EVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
P L ++ C++ D KRPK ++ +LE
Sbjct: 237 SPHVSKLMKI------CMNEDPAKRPKFDMIVPILE 266
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 44/176 (25%), Positives = 91/176 (51%), Gaps = 15/176 (8%)
Query: 184 LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVYEYVDNGNLDQWLHGD 241
+ RG E+ ++ E+ ++ ++ H N+V+L+ + + +V+E V+ G + +
Sbjct: 74 IQPRGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----ME 127
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
V + PL+ D KG+ YLH K++HRD+K SN+L+ + +++DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 302 KLLCSERSYVTTRVMGTFGYVAPEYACTG--MLNEKS-DVYSFGILIMEIITGRNP 354
+ ++ V GT ++APE + + K+ DV++ G+ + + G+ P
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 58.9 bits (141), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 28 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 85 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYAC 328
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR Y APE
Sbjct: 142 A---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 193
Query: 329 TGM-LNEKSDVYSFGILIMEIITGR 352
M N+ D++S G ++ E++ G+
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 93 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYAC 328
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR Y APE
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 329 TGM-LNEKSDVYSFGILIMEIITGR 352
M N+ D++S G ++ E++ G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 37 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 94 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 150
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 151 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 331 MLNEKSDVYSFGILIMEIIT------GRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 206 GYKENVDLWSVGCIMGEMVCHKILFPGRDYID 237
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 58.5 bits (140), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 158 VIGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAVK + N +K F+ EV + + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LV EY G + +L HG + + I+ + Y H+
Sbjct: 79 FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA---KFRQIVSAVQ---YCHQK 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+VHRD+K+ N+LLD N +++DFG + + + F AP YA
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSN------EFTFGNKLDAFC-GAPPYAAPE 182
Query: 331 MLNEKS------DVYSFGILIMEIITGRNPVD 356
+ K DV+S G+++ +++G P D
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 93 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYAC 328
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR Y APE
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 329 TGM-LNEKSDVYSFGILIMEIITGR 352
M N+ D++S G ++ E++ G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 331 MLNEKSDVYSFGILIMEIIT------GRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 195 GYKENVDLWSVGCIMGEMVCHKILFPGRDYID 226
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 45/277 (16%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK------VEVEVIGRVR----H 206
++G+GG+G V+ G L+D +VA+K + NR +EV ++ +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
++RLL + MLV E Q L + + PL + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 267 LHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
H VVHRD+K NIL+D R+ A++ DFG LL E T GT Y PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPE 208
Query: 326 YACTGMLNE-KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ + + V+S GIL+ +++ G P + + +E+++
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE---------------------RDQEILE 247
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+L PA + L+ RC+ P + RP + ++
Sbjct: 248 AEL-HFPAHVSPDCCALIR-RCLAPKPSSRPSLEEIL 282
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYM 352
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
APE D ++ G L+ E+I G++P + + + V+ L V SE
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 383 VDPKLPKMPASKALKRVLLVALRCVDP 409
P +++L LL C DP
Sbjct: 413 -------SPQARSLCSQLL----CKDP 428
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 30 LCE--VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 207 KNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDV-SPLTWDIRMNIILGTAK 262
++V LL Y +G M V+E++D +L + D G V S M IL +
Sbjct: 88 PHIVELLETYSSDGMLYM-VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---E 143
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 319
L Y H+ ++HRDVK +LL + N+ ++ FG+A L E V +GT
Sbjct: 144 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTP 199
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
++APE + DV+ G+++ +++G P
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/260 (26%), Positives = 107/260 (41%), Gaps = 33/260 (12%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------- 191
+ EL A S + I G YG V G+ S+G VA+K + N
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
K E+ ++ H N++ L V +++ + + +L Q +H +SP
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
M IL GL LHE VVHRD+ NILL + + DF LA+ ++
Sbjct: 134 QHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 308 RS---YVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363
+ YVT R Y APE + D++S G ++ E+ N R
Sbjct: 188 ANKTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF---NRKALFRGSTF 239
Query: 364 VNLVDWLKTMVGSRKSEEVV 383
N ++ + +VG+ K E+VV
Sbjct: 240 YNQLNKIVEVVGTPKIEDVV 259
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/260 (26%), Positives = 107/260 (41%), Gaps = 33/260 (12%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------- 191
+ EL A S + I G YG V G+ S+G VA+K + N
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
K E+ ++ H N++ L V +++ + + +L Q +H +SP
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
M IL GL LHE VVHRD+ NILL + + DF LA+ ++
Sbjct: 134 QHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 308 RS---YVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363
+ YVT R Y APE + D++S G ++ E+ N R
Sbjct: 188 ANKTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF---NRKALFRGSTF 239
Query: 364 VNLVDWLKTMVGSRKSEEVV 383
N ++ + +VG+ K E+VV
Sbjct: 240 YNQLNKIVEVVGTPKIEDVV 259
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFGYV- 322
LH V+HRD+K SN+L++ + +V DFGLA+++ ++ S T + G +V
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 323 -----APEYACTGMLNEKS-DVYSFGILIMEIITGR 352
APE T ++ DV+S G ++ E+ R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P+T + ++ A+G+ +L K +HRD+ + NILL ++ DFGLA+ +
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 307 ERSYV---TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362
YV TR+ ++APE + + KSDV+S+G+L+ EI + G +P Y Q
Sbjct: 252 NPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP--YPGVQM 307
Query: 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422
+ + L+ + R E + + + L C D +RP+ ++
Sbjct: 308 DEDFCSRLREGMRMRAPE-------------YSTPEIYQIMLDCWHRDPKERPRFAELVE 354
Query: 423 ML 424
L
Sbjct: 355 KL 356
Score = 37.0 bits (84), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V + GI T VAVK L +E K E++++ + H N+V
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 211 RLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C +G M++ EY GNL +L D+ L D +++ K L +
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSK-RDLFFLNKDAALHMEPKKEKMEPGLEQ 153
Query: 270 GLEPKV 275
G +P++
Sbjct: 154 GKKPRL 159
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYM 352
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
APE D ++ G L+ E+I G++P + + + V+ L V SE
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 383 VDPKLPKMPASKALKRVLLVALRCVDP 409
P +++L LL C DP
Sbjct: 413 -------SPQARSLCSQLL----CKDP 428
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 28 LCE--VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 207 KNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDV-SPLTWDIRMNIILGTAK 262
++V LL Y +G M V+E++D +L + D G V S M IL +
Sbjct: 86 PHIVELLETYSSDGMLYM-VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---E 141
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 319
L Y H+ ++HRDVK +LL + N+ ++ FG+A L E V +GT
Sbjct: 142 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTP 197
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
++APE + DV+ G+++ +++G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 74/300 (24%), Positives = 123/300 (41%), Gaps = 37/300 (12%)
Query: 111 SRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
+ G+G E + + G S LG + LR VIG G Y V
Sbjct: 25 AMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR-------------VIGRGSYAKVLLV 71
Query: 171 ILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML-V 225
L ++ VK L N + + E V + + + L C + R+ V
Sbjct: 72 RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131
Query: 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
EYV+ G+L H P + + A L YLHE +++RD+K N+
Sbjct: 132 IEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER---GIIYRDLKLDNV 184
Query: 286 LLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 342
LLD + + +++D+G +C E T+ GT Y+APE D ++ G
Sbjct: 185 LLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 343 ILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 400
+L+ E++ GR+P D S + N D+L ++ + ++ P+ + A+ LK L
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKAASVLKSFL 297
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLH-GDVGDVSPLTWDIRM 254
EV V+ + H N+++L + + LV E G L D+ +H +V
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV----- 140
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYV 311
II G+ YLH+ +VHRD+K N+LL+ + ++ DFGL+ + +++
Sbjct: 141 -IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-- 194
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+GT Y+APE +EK DV+S G+++ ++ G P
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G + +V R + T+ ++N + + ++ + E + ++H N+VRL
Sbjct: 39 LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A +H+ LE
Sbjct: 99 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIHQILESVN 144
Query: 274 -----KVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+VHRD+K N+LL + +++DFGLA + E+ GT GY++PE
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ-AWFGFAGTPGYLSPE 203
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ D+++ G+++ ++ G P
Sbjct: 204 VLRKDPYGKPVDIWACGVILYILLVGYPP 232
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL---DQWLHG-DVGDVSPL 248
+FK E+++I ++++ + G ++YEY++N ++ D++ D +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
+ II +Y+H E + HRDVK SNIL+D+ ++SDFG E
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFG-------ES 199
Query: 309 SYVTTRVM----GTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 362
Y+ + + GT+ ++ PE+ + K D++S GI + + N V +S
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY--VMFYNVVPFSLKIS 257
Query: 363 EVNLVDWLKT 372
V L + ++T
Sbjct: 258 LVELFNNIRT 267
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 49/287 (17%)
Query: 159 IGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++G+ + T+V +K L + F ++ ++ HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G CV G +LV E+V G+LD +L + ++ L W ++ + A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEEN 132
Query: 271 LEPKVVHRDVKSSNILLDRQWN--------ARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
++H +V + NILL R+ + ++SD G++ + + + R+ +V
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI----PWV 184
Query: 323 APEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
PE C LN +D +SFG + EI +G + +P L + RK
Sbjct: 185 PPE--CIENPKNLNLATDKWSFGTTLWEICSGGD-----KP---------LSALDSQRKL 228
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+ D ++PA KA + L+ C+D + RP +I L +
Sbjct: 229 QFYEDRH--QLPAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNS 272
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 18/229 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRLL 213
IG+G +G V +D K+ +N + E+ FK E++++ + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLW 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ +V + + G+L L +V + I L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ--- 134
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT---G 330
+++HRD+K NILLD + ++DF +A +L E T + GT Y+APE +
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGA 192
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
+ D +S G+ E++ GR P +V +T V + S
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 51/288 (17%)
Query: 159 IGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++G+ + T+V +K L + F ++ ++ HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY-LHE 269
G C G +LV E+V G+LD +L + ++ L W + + AK LA+ +H
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEV------AKQLAWAMHF 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
E ++H +V + NILL R+ + ++SD G++ + + + R+ +
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI----PW 183
Query: 322 VAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
V PE C LN +D +SFG + EI +G + +P L + RK
Sbjct: 184 VPPE--CIENPKNLNLATDKWSFGTTLWEICSGGD-----KP---------LSALDSQRK 227
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+ D ++PA KA + L+ C+D + RP +I L +
Sbjct: 228 LQFYEDRH--QLPAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNS 272
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 158 VIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V +LS+ K+ K+++ E VE V+
Sbjct: 348 VLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLALPGKPPF 403
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L C + R+ V EYV+ G+L + G + + + + I GL +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------GLFF 457
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-GTFGYVA 323
L +++RD+K N++LD + + +++DFG +C E + VTT+ GT Y+A
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKXFCGTPDYIA 510
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
PE + D ++FG+L+ E++ G+ P +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 27 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 87 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 140
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYACT 329
+++RD+K N+LLD + + +++D+G +C E T+ GT Y+APE
Sbjct: 141 -GIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
D ++ G+L+ E++ GR+P D S + N D+L ++ + ++ P+
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRS 252
Query: 388 PKMPASKALKRVL 400
+ A+ LK L
Sbjct: 253 MSVKAASVLKSFL 265
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 53/227 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
GL Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ R
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 317 G---TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 355
T Y PE +L E+ D++ G ++ E+ T R+P+
Sbjct: 188 NRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 12 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 72 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 125
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYACT 329
+++RD+K N+LLD + + +++D+G +C E T+ GT Y+APE
Sbjct: 126 -GIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
D ++ G+L+ E++ GR+P D S + N D+L ++ + ++ P+
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRS 237
Query: 388 PKMPASKALKRVL 400
+ A+ LK L
Sbjct: 238 LSVKAASVLKSFL 250
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 18/250 (7%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 129
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+++RD+K N+LLD + + +++D+G+ K T+ GT Y+APE
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSXFCGTPNYIAPEILRGEDY 187
Query: 333 NEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
D ++ G+L+ E++ GR+P D S + N D+L ++ + ++ P+ +
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSV 244
Query: 391 PASKALKRVL 400
A+ LK L
Sbjct: 245 KAASVLKSFL 254
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 158 VIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G ++ + G A+K L + K+ + E ++ V LV+L
Sbjct: 48 TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYLHEGLE 272
+ + +V EYV G + L +G S P I+L YLH
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT----FEYLHS--- 159
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+++RD+K N+L+D+Q +V+DFG AK + T + GT Y+APE +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRP 360
N+ D ++ G+LI E+ G P +P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 170
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 171 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 158 VIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V +LS+ K+ K+++ E VE V+
Sbjct: 27 VLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLALPGKPPF 82
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L C + R+ V EYV+ G+L + G + + + + I GL +
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------GLFF 136
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-GTFGYVA 323
L +++RD+K N++LD + + +++DFG +C E + VTT+ GT Y+A
Sbjct: 137 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKXFCGTPDYIA 189
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
PE + D ++FG+L+ E++ G+ P +
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 170
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 171 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTL 219
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIIT------GRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 201 GYKENVDIWSVGCIMGEMVCHKILFPGRDYID 232
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT-- 133
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
IG+G + +V R + L G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + LV++ V G L + D+ + + I + + + H+ V
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 124
Query: 276 VHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPEVLRKEAY 183
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+ D+++ G+++ ++ G P
Sbjct: 184 GKPVDIWACGVILYILLVGYPP 205
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT-- 133
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 158 VIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G ++ + G A+K L + K+ + E ++ V LV+L
Sbjct: 48 TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYLHEGLE 272
+ + +V EY+ G++ L +G S P I+L YLH
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLT----FEYLHS--- 159
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+++RD+K N+L+D+Q +V+DFG AK + T + GT Y+APE +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRP 360
N+ D ++ G+LI E+ G P +P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 53/227 (23%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 129
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
GL Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ R
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 317 G---TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 355
T Y PE +L E+ D++ G ++ E+ T R+P+
Sbjct: 187 NRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT-- 133
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 53/227 (23%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
GL Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ R
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 317 G---TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 355
T Y PE +L E+ D++ G ++ E+ T R+P+
Sbjct: 188 NRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 53/227 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKASIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
GL Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ R
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 317 G---TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 355
T Y PE +L E+ D++ G ++ E+ T R+P+
Sbjct: 188 NRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT-- 133
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
K+ H D+K NI LLD+ + ++ DFGLA + E + GT +VAPE
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
L ++D++S G++ +++G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 158 VIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G ++ + G A+K L + K+ + E ++ V LV+L
Sbjct: 48 TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYLHEGLE 272
+ + +V EY+ G++ L +G S P I+L YLH
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLT----FEYLHS--- 159
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+++RD+K N+L+D+Q +V+DFG AK + T + GT Y+APE +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRP 360
N+ D ++ G+LI E+ G P +P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTL 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 171
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 172 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 220
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFGLAK + T + GT Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 84 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 142
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 143 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 191
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIIT------GRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 201 GYKENVDLWSVGCIMGEMVCHKILFPGRDYID 232
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 152 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+L+D+Q +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 84 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 144 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 192
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLL 213
V+G+G +G V + G AVK L + + + + E ++ R+ + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V E+V+ G+L + II L +LH+
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII----SALMFLHDK-- 143
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL-LCSERSYVTTRVMGTFGYVAPEYACTGM 331
+++RD+K N+LLD + + +++DFG+ K +C+ T GT Y+APE +
Sbjct: 144 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEML 200
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
D ++ G+L+ E++ G P +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE 225
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 22/186 (11%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P +S + +V+L
Sbjct: 172 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSL 228
Query: 367 VDWLKT 372
D + +
Sbjct: 229 KDQITS 234
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 22/186 (11%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 69 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 128 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 177
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P +S + +V+L
Sbjct: 178 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSL 234
Query: 367 VDWLKT 372
D + +
Sbjct: 235 KDQITS 240
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 86 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 146 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 194
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 195 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFGLAK + T + GT Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 77 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 135
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 136 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTL 184
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 62 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 121 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 170
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P R Q
Sbjct: 171 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--- 226
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
LK + S K + P++ + KAL L+ L VDP A
Sbjct: 227 ---LKDQITSGKYNFI--PEVWAEVSEKALD--LVKKLLVVDPKA 264
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 22/186 (11%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P +S + +V+L
Sbjct: 172 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSL 228
Query: 367 VDWLKT 372
D + +
Sbjct: 229 KDQITS 234
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 108
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 166 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 108
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 166 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 22/186 (11%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P +S + +V+L
Sbjct: 172 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSL 228
Query: 367 VDWLKT 372
D + +
Sbjct: 229 KDQITS 234
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL---- 213
+G GG G+V+ + +D K VA+K ++ Q+ K E+++I R+ H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 214 ----------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
G E +V EY++ +V + PL + + +G
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDL------ANVLEQGPLLEEHARLFMYQLLRG 132
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYV--TTRVMGTFG 320
L Y+H V+HRD+K +N+ ++ + ++ DFGLA+++ S+ + + T
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 321 YVAPEYACTGMLNEKS-DVYSFGILIMEIITGRN 353
Y +P + K+ D+++ G + E++TG+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 12/167 (7%)
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
E + E+ V+ +++H+N+V L + LV + V G L + + T
Sbjct: 64 ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTE 119
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSE 307
+I + YLH +VHRD+K N+L D + +SDFGL+K+
Sbjct: 120 KDASTLIRQVLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EG 174
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ V + GT GYVAPE ++ D +S G++ ++ G P
Sbjct: 175 KGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 247 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 296
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P R Q
Sbjct: 297 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--- 352
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
LK + S K + P++ + KAL L+ L VDP A
Sbjct: 353 ---LKDQITSGKYNFI--PEVWAEVSEKALD--LVKKLLVVDPKA 390
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E ++ Q L + + L ++ + + + + H
Sbjct: 75 VIRLLDWFERPDSFVLILERMEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVYRGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLG 214
IG G +G+ R + TK VAVK + RG A E V+ E+I +RH N+VR
Sbjct: 28 IGSGNFGVA-RLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKE 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + ++ EY G L+ + + + D G++Y H +
Sbjct: 84 VILTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---Q 136
Query: 275 VVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+ HRD+K N LLD R + DFG +K +T +GT Y+APE
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEY 194
Query: 333 NEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+++D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS 309
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+L E S
Sbjct: 261 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 310
Query: 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
+ T + GT Y+APE T N D +S G+++ ++G P R Q
Sbjct: 311 LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--- 366
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 411
LK + S K + P++ + KAL L+ L VDP A
Sbjct: 367 ---LKDQITSGKYNFI--PEVWAEVSEKALD--LVKKLLVVDPKA 404
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 38/277 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+ E G +++G G + VK L + + ++F E + H N++ +LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 217 --VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ L+ + G+L LH V + ++ L A+G A+LH LEP
Sbjct: 77 QSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKF--ALDXARGXAFLH-TLEPL 133
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGM-- 331
+ + S ++ +D AR+S + S R Y +VAPE
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP-------AWVAPEALQKKPED 186
Query: 332 LNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK- 389
N +S D +SF +L+ E++T EV D +G + + E + P +P
Sbjct: 187 TNRRSADXWSFAVLLWELVT-----------REVPFADLSNXEIGXKVALEGLRPTIPPG 235
Query: 390 -MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
P L ++ C + D KRPK ++ +LE
Sbjct: 236 ISPHVSKLXKI------CXNEDPAKRPKFDXIVPILE 266
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+L L L+ +VHRD+K NILLD N +++DFG + L + V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV 183
Query: 316 MGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNP 354
GT Y+APE M ++ D++S G+++ ++ G P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI ++ G P +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + +AE E+ + +V L G
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 153
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q V + L D + + +GL YLH ++
Sbjct: 154 VREGPWVNIFMELLEGGSLGQL----VKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 206
Query: 276 VHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE---RSYVT-TRVMGTFGYVAPEYACTG 330
+H DVK+ N+LL +A + DFG A L + +S +T + GT ++APE
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ K DV+S +++ ++ G +P
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHP 290
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 118
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+L L L+ +VHRD+K NILLD N +++DFG + L + V
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV 170
Query: 316 MGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNP 354
GT Y+APE M ++ D++S G+++ ++ G P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 78 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 136
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D Q +V+DFG AK + T +
Sbjct: 137 IVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXL 185
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+APE + N+ D ++ G+LI E+ G P +P
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 43/237 (18%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 75 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCSERSYVTTRV 315
K++HRD+K NIL+ D+Q A +SDFGL K L S +S T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 316 ---MGTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIIT-GRNPV--DYSR 359
GT G+ APE L D++S G + I++ G++P YSR
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 90 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 90 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+L L L+ +VHRD+K NILLD N +++DFG + L + V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRSV 183
Query: 316 MGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNP 354
GT Y+APE M ++ D++S G+++ ++ G P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
T GT Y PE+ + +S V+S GIL+ +++ G P ++
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 220
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
T GT Y PE+ + +S V+S GIL+ +++ G P ++
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 63 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 180 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 233
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 264
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+++D+Q +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
PE + N+ D ++ G+LI E+ G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
T GT Y PE+ + +S V+S GIL+ +++ G P ++
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 75 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 23 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 83 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 139
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 140 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 193
Query: 313 TRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
T GT Y PE+ + +S V+S GIL+ +++ G P ++
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 239
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + + GT +VAPE L ++D++S G++ +++G +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 39/233 (16%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 93 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCSERSYVTTRV 315
K++HRD+K NIL+ D+Q A +SDFGL K L S + +
Sbjct: 151 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 316 ---MGTFGYVAPEY---ACTGMLNEKSDVYSFGILIMEIIT-GRNPV--DYSR 359
GT G+ APE + L D++S G + I++ G++P YSR
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 39/233 (16%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 93 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCSERSYVTTRV 315
K++HRD+K NIL+ D+Q A +SDFGL K L S + +
Sbjct: 151 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 316 ---MGTFGYVAPEY---ACTGMLNEKSDVYSFGILIMEIIT-GRNPV--DYSR 359
GT G+ APE + L D++S G + I++ G++P YSR
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT Y+AP + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 49/303 (16%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG 202
L+E + L +IG+G +G VY G + + ++ + K FK EV
Sbjct: 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL-----DQWLHGDVGDVSPLTWDIRMNII 257
+ RH+N+V +G C+ + ++ L D + DV + +I
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI----- 139
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKL---LCSERSYVT 312
KG+ YLH ++H+D+KS N+ D N +V +DFGL + L + R
Sbjct: 140 ---VKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 313 TRVM-GTFGYVAPEYACTGM---------LNEKSDVYSFGILIMEIITGRNPVDYSRPQG 362
R+ G ++APE ++ SDV++ G + E+ P ++P
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQP-- 247
Query: 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422
+ W +G+ + P L ++ K + +LL C + +RP ++
Sbjct: 248 -AEAIIW---QMGTG-----MKPNLSQIGMGKEISDILLF---CWAFEQEERPTFTKLMD 295
Query: 423 MLE 425
MLE
Sbjct: 296 MLE 298
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKV--AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
EN IG G +G V + + GT++ A K + + FK E+E++ + H N++RL
Sbjct: 14 ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV E G L ++ +H V S I+ +AY H+
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 125
Query: 273 PKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
V HRD+K N L ++ DFGLA + T +GT YV+P+
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ-VLE 181
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
G+ + D +S G+++ ++ G P +S P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP--FSAP 210
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 40/199 (20%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +GIV+R + + K + + +G + K E+ ++ RH+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++++E++ ++ + ++ +++ ++ + + L +LH + H
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVCEALQFLHSH---NIGHF 126
Query: 279 DVKSSNILLD--RQWNARVSDFGLAKLLCSERSYVTTRVMGTF-GYVAPEYACTGMLNEK 335
D++ NI+ R ++ +FG A+ L ++ R++ T Y APE +++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 336 SDVYSFGILIMEIITGRNP 354
+D++S G L+ +++G NP
Sbjct: 184 TDMWSLGTLVYVLLSGINP 202
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 14 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 74 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 131 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 184
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKV--AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
EN IG G +G V + + GT++ A K + + FK E+E++ + H N++RL
Sbjct: 31 ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV E G L ++ +H V S I+ +AY H+
Sbjct: 90 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 142
Query: 273 PKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
V HRD+K N L ++ DFGLA + T +GT YV+P+
Sbjct: 143 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ-VLE 198
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
G+ + D +S G+++ ++ G P +S P
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPP--FSAP 227
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK---------EFKVEVEVIGRVRHKNL 209
+G G +G V+ + + K V + E + +E+ ++ RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VRLLGYCVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+++L + LV E +G +L ++ PL I ++ +A G L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV--SAVGYLRLK 149
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ ++HRD+K NI++ + ++ DFG A L ER + GT Y APE
Sbjct: 150 D-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVLM 202
Query: 329 -TGMLNEKSDVYSFGILIMEIITGRNP 354
+ +++S G+ + ++ NP
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENP 229
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 128 NX---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGT 318
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGT 318
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D + ++ DFG LL + V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 328 CTGMLNEKS-DVYSFGILIMEIITGRNPVDY 357
+ +S V+S GIL+ +++ G P ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGT 318
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 157 NVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+++GEG YG V + S+ K+ K L E K E++++ R+RHKN+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 212 LLG--YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L+ Y E +V EY G + + L P+ GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--AHGYFCQLIDGLEYLHS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-MGTFGYVAPEYA- 327
+VH+D+K N+LL ++S G+A+ L + T R G+ + PE A
Sbjct: 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 328 -CTGMLNEKSDVYSFGILIMEIITGRNPVD 356
K D++S G+ + I TG P +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGT 318
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V KV LL+ ++ F E +++ +V+L
Sbjct: 82 VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ Y +V EY+ G+L + DV P W TA+ + L
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AKFYTAEVVLALDAIHS 192
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
++HRDVK N+LLD+ + +++DFG + +GT Y++PE +
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 330 -GMLNEKSDVYSFGILIMEIITGRNPV 355
G + D +S G+ + E++ G P
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTPF 279
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 27 IGAGNFGVA--RLMRDKQANELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYAHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V HRD+K N LLD R ++DFG +K S +GT Y+APE
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSK--ASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 332 LNEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + + T GT Y+
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 319
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + + T GT Y+
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 44/204 (21%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+GEG + I + + + +++ R +A + ++ + H N+V+L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-GHPNIVKLHEVFHD 77
Query: 219 GAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ LV E ++ G L + + H + S I+ ++++H+
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHMHD---VG 126
Query: 275 VVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
VVHRD+K N+L + ++ DFG A+L + + T T Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNG 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPV 355
+E D++S G+++ +++G+ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPF 209
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L YLH +++RD+K N+L+D+Q +V+DFG AK + T +
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
GT +APE + N+ D ++ G+LI E+ G P +P
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + +AE E+ + +V L G
Sbjct: 82 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 134
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q V + L D + + +GL YLH ++
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL----VKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 187
Query: 276 VHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE---RSYVT-TRVMGTFGYVAPEYACTG 330
+H DVK+ N+LL +A + DFG A L + + +T + GT ++APE
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ K DV+S +++ ++ G +P
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHP 271
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYC 216
+G G Y V+ I +++ KV VK L + + + K E++++ +R N++ L
Sbjct: 45 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKNKIKREIKILENLRGGPNIITLADIV 101
Query: 217 VEGAYRM--LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ R LV+E+V+N + Q L+ + D +DIR + K L Y H
Sbjct: 102 KDPVSRTPALVFEHVNNTDFKQ-LYQTLTD-----YDIRF-YMYEILKALDYCHSM---G 151
Query: 275 VVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
++HRDVK N+++D + R+ D+GLA+ + Y RV + + PE +
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMY 209
Query: 334 EKS-DVYSFGILIMEIITGRNPV 355
+ S D++S G ++ +I + P
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPF 232
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 18/222 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEV 198
+R+L VIG G +G V KV LL+ ++ F E
Sbjct: 66 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNII 257
+++ +V+L + Y +V EY+ G+L + DV P W
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 176
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
TA+ + L +HRDVK N+LLD+ + +++DFG + E +G
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 318 TFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPV 355
T Y++PE + G + D +S G+ + E++ G P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 18/222 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEV 198
+R+L VIG G +G V KV LL+ ++ F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNII 257
+++ +V+L + Y +V EY+ G+L + DV P W
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 171
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
TA+ + L +HRDVK N+LLD+ + +++DFG + E +G
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 318 TFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPV 355
T Y++PE + G + D +S G+ + E++ G P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 18/222 (8%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEV 198
+R+L VIG G +G V KV LL+ ++ F E
Sbjct: 66 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNII 257
+++ +V+L + Y +V EY+ G+L + DV P W
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 176
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
TA+ + L +HRDVK N+LLD+ + +++DFG + E +G
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 318 TFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPV 355
T Y++PE + G + D +S G+ + E++ G P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 26 IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 81 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 133
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V HRD+K N LLD R + DFG +K +T +GT Y+APE
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 191
Query: 332 LNEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFE 217
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + L+++ V G L + D+ + + I + + + H+ V
Sbjct: 90 ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 142
Query: 276 VHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+K N+LL + +++DFGLA + E+ GT GY++PE
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPY 201
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+ D+++ G+++ ++ G P
Sbjct: 202 GKPVDLWACGVILYILLVGYPP 223
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 158 VIGEGGYGIVYRGILS--DGT--KVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNLVR 211
++G+G +G V L DG+ KVAVK L + + +EF E + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 212 LLGYCVEGAYR------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKG 263
L+G + + M++ ++ +G+L +L +P ++ + ++ A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFG 320
+ YL +HRD+ + N +L V+DFGL++ + S Y +++
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVK 204
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++A E + SDV++FG+ + EI+T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + + T GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + + T GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + + T GT Y+
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 175
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 39/246 (15%)
Query: 132 VSHLGWGRWYT--LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
+ +L W + +T ++++ VIG G +G V L + KV +LN
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 190 AEKE----FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL----DQWLHGD 241
++ F+ E +V+ K + L Y + D+ NL D ++ GD
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLH------------YAFQDDNNLYLVMDYYVGGD 160
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGL-------EPKVVHRDVKSSNILLDRQWNAR 294
+ LT + L YL E + + VHRD+K NIL+D + R
Sbjct: 161 L-----LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
Query: 295 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEII 349
++DFG L + + ++ +GT Y++PE G + D +S G+ + E++
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 350 TGRNPV 355
G P
Sbjct: 276 YGETPF 281
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 38/79 (48%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
HRDVK NIL+ A + DFG+A E+ +GT Y APE +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 336 SDVYSFGILIMEIITGRNP 354
+D+Y+ ++ E +TG P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 75 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCSERSYVTTRV 315
K++HRD+K NIL+ D+Q A +SDFGL K L S + +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 316 ---MGTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIIT-GRNPV--DYSR 359
GT G+ APE L D++S G + I++ G++P YSR
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + + E E+ + +V L G
Sbjct: 66 VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q + + L D + + +GL YLH ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHT---RRI 171
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSE---RSYVT-TRVMGTFGYVAPEYACTG 330
+H DVK+ N+LL + A + DFG A L + +S +T + GT ++APE
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ K D++S +++ ++ G +P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + + E E+ + +V L G
Sbjct: 82 VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 134
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q + + L D + + +GL YLH ++
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHT---RRI 187
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSE---RSYVT-TRVMGTFGYVAPEYACTG 330
+H DVK+ N+LL + A + DFG A L + +S +T + GT ++APE
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ K D++S +++ ++ G +P
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHP 271
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A + + LE
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIQQILESVN 117
Query: 274 -----KVVHRDVKSSNILLDRQWN---ARVSDFGLA-KLLCSERSYVTTRVMGTFGYVAP 324
+VHRD+K N+LL + +++DFGLA ++ ++++ GT GY++P
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSP 175
Query: 325 EYACTGMLNEKSDVYSFGILIMEIITGRNP 354
E + D+++ G+++ ++ G P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + + E E+ + +V L G
Sbjct: 80 LGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 132
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q + + L D + + +GL YLH ++
Sbjct: 133 VREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHT---RRI 185
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSE---RSYVT-TRVMGTFGYVAPEYACTG 330
+H DVK+ N+LL + A + DFG A L + +S +T + GT ++APE
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ K D++S +++ ++ G +P
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHP 269
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQ-AEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G + +V + I S G + A K L R GQ E E+ V+ + V L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 216 CVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E + L+ EY G + ++ ++ IR+ I +G+ YLH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL--IKQILEGVYYLHQN---N 151
Query: 275 VVHRDVKSSNILLDRQW---NARVSDFGLAKLL---CSERSYVTTRVMGTFGYVAPEYAC 328
+VH D+K NILL + + ++ DFG+++ + C R +MGT Y+APE
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-----EIMGTPEYLAPEILN 206
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
+ +D+++ GI+ ++T +P
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSP 232
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A + + LE
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIQQILESVN 117
Query: 274 -----KVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+VHRD+K N+LL + +++DFGLA + ++ GT GY++PE
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPE 176
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ D+++ G+++ ++ G P
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ + V+ E+I +RH N+VR
Sbjct: 27 IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGE-KIAANVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V HRD+K N LLD R + DFG +K +T +GT Y+APE
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 192
Query: 332 LNEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + GT Y+
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYL 178
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + GT Y+
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYL 176
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + GT Y+
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYL 177
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYL 177
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYL 172
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL--DQWLHGDVGDVSPLTWDIRM 254
EV V+ ++ H N+++L + + LV E G L + L +V
Sbjct: 71 EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----- 125
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYV 311
I+ G YLH+ +VHRD+K N+LL+ R ++ DFGL+ E
Sbjct: 126 -IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 179
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+GT Y+APE +EK DV+S G+++ ++ G P
Sbjct: 180 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL--DQWLHGDVGDVSPLTWDIRM 254
EV V+ ++ H N+++L + + LV E G L + L +V
Sbjct: 54 EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----- 108
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYV 311
I+ G YLH+ +VHRD+K N+LL+ R ++ DFGL+ E
Sbjct: 109 -IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 162
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+GT Y+APE +EK DV+S G+++ ++ G P
Sbjct: 163 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 204
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYL 172
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 64/247 (25%), Positives = 97/247 (39%), Gaps = 56/247 (22%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IG+G YG+V I + K+ KN + + E K EV ++ ++ H N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD-------------VSPL----------- 248
+ Y LV E G+L L+ + D + P
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 249 ------TWDIRM------NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQWNAR 294
+ D NI+ L YLH + HRD+K N L ++ + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 295 VSDFGLAK---LLCSERSYVTTRVMGTFGYVAPEYACTGMLNE----KSDVYSFGILIME 347
+ DFGL+K L + Y T GT +VAPE T NE K D +S G+L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHL 268
Query: 348 IITGRNP 354
++ G P
Sbjct: 269 LLMGAVP 275
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
LV+EY++N + Q L+ + D +DIR + K L Y H ++HRDVK
Sbjct: 112 LVFEYINNTDFKQ-LYQILTD-----FDIRF-YMYELLKALDYCHSK---GIMHRDVKPH 161
Query: 284 NILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-DVYSF 341
N+++D Q R+ D+GLA+ + Y RV + + PE + + S D++S
Sbjct: 162 NVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 219
Query: 342 GILIMEIITGRNPV 355
G ++ +I R P
Sbjct: 220 GCMLASMIFRREPF 233
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYL 172
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
APE D + G+++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
LV+EY++N + Q L+ + D +DIR + K L Y H ++HRDVK
Sbjct: 117 LVFEYINNTDFKQ-LYQILTD-----FDIRF-YMYELLKALDYCHSK---GIMHRDVKPH 166
Query: 284 NILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-DVYSF 341
N+++D Q R+ D+GLA+ + Y RV + + PE + + S D++S
Sbjct: 167 NVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 224
Query: 342 GILIMEIITGRNPV 355
G ++ +I R P
Sbjct: 225 GCMLASMIFRREPF 238
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLV 210
+++IG G YG VY + K VA+K + NR + K E+ ++ R++ ++
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 211 RLLGYCVEGAY----RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
RL + + + + + +L + + I N++LG +
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN----F 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
+HE ++HRD+K +N LL++ + +V DFGLA+ + SE+
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 27 IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V HRD+K N LLD R + FG +K +T +GT Y+APE
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 192
Query: 332 LNEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY 215
++GEG Y V + L +G + AVK + G + EVE + + + +KN++ L+ +
Sbjct: 20 LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 216 CVEGAYRMLVYEYVDNGNL----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ LV+E + G++ + H + + S + D+ A L +LH
Sbjct: 80 FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDV--------AAALDFLHT-- 129
Query: 272 EPKVVHRDVKSSNILL---DRQWNARVSDFGLA---KLLCSERSYVT---TRVMGTFGYV 322
+ HRD+K NIL ++ ++ DF L KL S T T G+ Y+
Sbjct: 130 -KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 323 APEYA-----CTGMLNEKSDVYSFGILIMEIITGRNP 354
APE +++ D++S G+++ +++G P
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLV 210
+++IG G YG VY + K VA+K + NR + K E+ ++ R++ ++
Sbjct: 33 KHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 90
Query: 211 RLLGYCV-EGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
RL + E + +V E D +L + + I N++LG
Sbjct: 91 RLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLGEK---- 145
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
++HE ++HRD+K +N LL++ + ++ DFGLA+ + S++
Sbjct: 146 FIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 27 IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAK--LLCSERSYVTTRVMGTFGYVAPEYACT 329
+V HRD+K N LLD R + FG +K +L S+ +GT Y+APE
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ----PKDTVGTPAYIAPEVLLK 190
Query: 330 GMLNEK-SDVYSFGILIMEIITGRNPVD 356
+ K +DV+S G+ + ++ G P +
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/202 (21%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G + +V R + + ++N + + ++ + E + ++H N+VRL
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + L+++ V G L + D+ + + I + + + H+ V
Sbjct: 79 ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 131
Query: 276 VHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHR++K N+LL + +++DFGLA + E+ GT GY++PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPY 190
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+ D+++ G+++ ++ G P
Sbjct: 191 GKPVDLWACGVILYILLVGYPP 212
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKV---------EVEVIGRVRH-KNLVRLLGYC 216
V +L G V + N R Q + K+ EVE+ R ++VR++
Sbjct: 35 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD-V 93
Query: 217 VEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
E Y ++V E +D G L + D GD + T I+ + + YLH
Sbjct: 94 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI- 150
Query: 272 EPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ HRDVK N+L ++ NA +++DFG AK S S T T YVAPE
Sbjct: 151 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 206
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D++S G+++ ++ G P
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPP 232
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKV---------EVEVIGRVRH-KNLVRLLGYC 216
V +L G V + N R Q + K+ EVE+ R ++VR++
Sbjct: 25 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD-V 83
Query: 217 VEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
E Y ++V E +D G L + D GD + T I+ + + YLH
Sbjct: 84 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI- 140
Query: 272 EPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ HRDVK N+L ++ NA +++DFG AK S S T T YVAPE
Sbjct: 141 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 196
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D++S G+++ ++ G P
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYPP 222
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKV---------EVEVIGRVRH-KNLVRLLGYC 216
V +L G V + N R Q + K+ EVE+ R ++VR++
Sbjct: 27 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD-V 85
Query: 217 VEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
E Y ++V E +D G L + D GD + T I+ + + YLH
Sbjct: 86 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI- 142
Query: 272 EPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ HRDVK N+L ++ NA +++DFG AK S S T T YVAPE
Sbjct: 143 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 198
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++ D++S G+++ ++ G P
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYPP 224
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.317 0.136 0.403
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 14,215,579
Number of Sequences: 62578
Number of extensions: 608596
Number of successful extensions: 3683
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 843
Number of HSP's successfully gapped in prelim test: 248
Number of HSP's that attempted gapping in prelim test: 1209
Number of HSP's gapped (non-prelim): 1137
length of query: 484
length of database: 14,973,337
effective HSP length: 103
effective length of query: 381
effective length of database: 8,527,803
effective search space: 3249092943
effective search space used: 3249092943
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 53 (25.0 bits)